activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2470393	CHEMBL981775	Inhibition of SNF1LK2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5699	Homo sapiens	INH	%	10.0
	2470393	CHEMBL981775	Inhibition of SNF1LK2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5699	Homo sapiens	INH	%	10.0
Not Evaluated	2476727	CHEMBL982755	Binding affinity to human QIK at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL5699	Homo sapiens	Activity		
Not Evaluated	2478566	CHEMBL982755	Binding affinity to human QIK at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL5699	Homo sapiens	Activity		
Not Evaluated	2478769	CHEMBL982755	Binding affinity to human QIK at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL5699	Homo sapiens	Activity		
Not Evaluated	2479624	CHEMBL982755	Binding affinity to human QIK at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL5699	Homo sapiens	Activity		
	2479827	CHEMBL982755	Binding affinity to human QIK at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	16.7	CHEMBL5699	Homo sapiens	Activity	%	16.7
	2480624	CHEMBL982755	Binding affinity to human QIK at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	0.8	CHEMBL5699	Homo sapiens	Activity	%	0.8
	2480826	CHEMBL982755	Binding affinity to human QIK at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	18.0	CHEMBL5699	Homo sapiens	Activity	%	18.0
Not Evaluated	2577245	CHEMBL982755	Binding affinity to human QIK at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL5699	Homo sapiens	Activity		
	2577448	CHEMBL982755	Binding affinity to human QIK at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337	=	Activity	%	17.3	CHEMBL5699	Homo sapiens	Activity	%	17.3
	2593653	CHEMBL982755	Binding affinity to human QIK at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	3.3	CHEMBL5699	Homo sapiens	Activity	%	3.3
	2593919	CHEMBL982755	Binding affinity to human QIK at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	1.3	CHEMBL5699	Homo sapiens	Activity	%	1.3
Not Evaluated	2594122	CHEMBL982755	Binding affinity to human QIK at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL5699	Homo sapiens	Activity		
Not Evaluated	2594862	CHEMBL982755	Binding affinity to human QIK at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL5699	Homo sapiens	Activity		
Not Evaluated	2595065	CHEMBL982755	Binding affinity to human QIK at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL5699	Homo sapiens	Activity		
	2596262	CHEMBL982755	Binding affinity to human QIK at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	10.8	CHEMBL5699	Homo sapiens	Activity	%	10.8
Not Evaluated	2596465	CHEMBL982755	Binding affinity to human QIK at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL5699	Homo sapiens	Activity		
Not Evaluated	2597734	CHEMBL982755	Binding affinity to human QIK at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL5699	Homo sapiens	Activity		
	2896036	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896037	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896038	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896039	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896040	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896041	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896042	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	3700.0	CHEMBL5699	Homo sapiens	Kd	nM	3700.0
	2896043	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896044	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	4900.0	CHEMBL5699	Homo sapiens	Kd	nM	4900.0
	2896045	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896046	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896047	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	6.4	CHEMBL5699	Homo sapiens	Kd	nM	6.4
	2896048	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	4500.0	CHEMBL5699	Homo sapiens	Kd	nM	4500.0
	2896049	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896050	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896051	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	2100.0	CHEMBL5699	Homo sapiens	Kd	nM	2100.0
	2896052	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896053	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	7300.0	CHEMBL5699	Homo sapiens	Kd	nM	7300.0
	2896054	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896055	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	1600.0	CHEMBL5699	Homo sapiens	Kd	nM	1600.0
	2896056	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896057	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896058	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896059	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896060	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896061	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	560.0	CHEMBL5699	Homo sapiens	Kd	nM	560.0
	2896062	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896063	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896064	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896065	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896066	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896067	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896068	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1.1	CHEMBL5699	Homo sapiens	Kd	nM	1.1
	2896069	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	750.0	CHEMBL5699	Homo sapiens	Kd	nM	750.0
	2896070	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	580.0	CHEMBL5699	Homo sapiens	Kd	nM	580.0
	2896071	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1700.0	CHEMBL5699	Homo sapiens	Kd	nM	1700.0
	2896072	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	2896073	CHEMBL1061982	Binding constant for full-length SNF1LK2	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	430.0	CHEMBL5699	Homo sapiens	Kd	nM	430.0
	2922000	CHEMBL1052968	Inhibition of SNF1LK2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL5699	Homo sapiens	Activity	%	100.0
	3052484	CHEMBL1072522	Residual activity of SNF1LK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	88.0	CHEMBL5699	Homo sapiens	Residual activity	%	88.0
	3052736	CHEMBL1043815	Residual activity of SNF1LK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	85.0	CHEMBL5699	Homo sapiens	Residual activity	%	85.0
	3054045	CHEMBL1071375	Residual activity of SNF1LK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	241.0	CHEMBL5699	Homo sapiens	Residual activity	%	241.0
	3055332	CHEMBL1072522	Residual activity of SNF1LK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	93.0	CHEMBL5699	Homo sapiens	Residual activity	%	93.0
	3055584	CHEMBL1043815	Residual activity of SNF1LK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	88.0	CHEMBL5699	Homo sapiens	Residual activity	%	88.0
	3056889	CHEMBL1071375	Residual activity of SNF1LK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	141.0	CHEMBL5699	Homo sapiens	Residual activity	%	141.0
	3057141	CHEMBL1072522	Residual activity of SNF1LK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	80.0	CHEMBL5699	Homo sapiens	Residual activity	%	80.0
	3058461	CHEMBL1043815	Residual activity of SNF1LK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	78.0	CHEMBL5699	Homo sapiens	Residual activity	%	78.0
	3059745	CHEMBL1071375	Residual activity of SNF1LK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	107.0	CHEMBL5699	Homo sapiens	Residual activity	%	107.0
	3214033	CHEMBL1103228	Inhibition of QIK at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	93.0	CHEMBL5699	Homo sapiens	INH	%	93.0
	3224962	CHEMBL1101766	Inhibition of SNF1LK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL5699	Homo sapiens	INH	%	50.0
	3226341	CHEMBL1101766	Inhibition of SNF1LK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL5699	Homo sapiens	INH	%	50.0
	3332153	CHEMBL1167701	Inhibition of SIK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5699	Homo sapiens	INH	%	50.0
	3333568	CHEMBL1167701	Inhibition of SIK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5699	Homo sapiens	INH	%	50.0
	3334973	CHEMBL1167701	Inhibition of SIK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5699	Homo sapiens	INH	%	50.0
	3336393	CHEMBL1167701	Inhibition of SIK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5699	Homo sapiens	INH	%	50.0
	3339238	CHEMBL1167701	Inhibition of SIK2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL5699	Homo sapiens	INH	%	50.0
	3340541	CHEMBL1167701	Inhibition of SIK2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL5699	Homo sapiens	INH	%	50.0
	3341935	CHEMBL1167701	Inhibition of SIK2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	=	Inhibition	%	75.0	CHEMBL5699	Homo sapiens	INH	%	75.0
	3343382	CHEMBL1167701	Inhibition of SIK2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5699	Homo sapiens	INH	%	50.0
	3351758	CHEMBL1175338	Inhibition of SIK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	18.0	CHEMBL5699	Homo sapiens	INH	%	18.0
	3358810	CHEMBL1175338	Inhibition of SIK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	21.0	CHEMBL5699	Homo sapiens	INH	%	21.0
	3448626	CHEMBL1244979	Binding affinity to SIK2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	3448783	CHEMBL1244979	Binding affinity to SIK2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	15.0	CHEMBL5699	Homo sapiens	Kd	nM	15.0
	3449049	CHEMBL1244979	Binding affinity to SIK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	560.0	CHEMBL5699	Homo sapiens	Kd	nM	560.0
	3449341	CHEMBL1244979	Binding affinity to SIK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	90.0	CHEMBL5699	Homo sapiens	Kd	nM	90.0
	3449342	CHEMBL1244979	Binding affinity to SIK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	580.0	CHEMBL5699	Homo sapiens	Kd	nM	580.0
	3449853	CHEMBL1244979	Binding affinity to SIK2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	3450244	CHEMBL1244979	Binding affinity to SIK2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	uM	10.0
	5123946	CHEMBL1647805	Inhibition of SNFILK2 at 10 uM	B	Nc1nccc2cc(O[C@H]3CCCNC3)ccc12		CHEMBL1643368	>	Inhibition	%	80.0	CHEMBL5699	Homo sapiens	INH	%	80.0
	6339931	CHEMBL1826614	Activity of SIK2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	75.0	CHEMBL5699	Homo sapiens	Activity	%	75.0
	7567512	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7567983	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	3300.0	CHEMBL5699	Homo sapiens	Kd	nM	3300.0
	7568451	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	26.0	CHEMBL5699	Homo sapiens	Kd	nM	26.0
	7568883	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	750.0	CHEMBL5699	Homo sapiens	Kd	nM	750.0
	7569026	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	2100.0	CHEMBL5699	Homo sapiens	Kd	nM	2100.0
	7569486	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7569958	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7570421	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	2500.0	CHEMBL5699	Homo sapiens	Kd	nM	2500.0
	7570848	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	580.0	CHEMBL5699	Homo sapiens	Kd	nM	580.0
	7571002	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7571459	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	200.0	CHEMBL5699	Homo sapiens	Kd	nM	200.0
	7571935	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7572398	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7572814	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	17.0	CHEMBL5699	Homo sapiens	Kd	nM	17.0
	7572983	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7573440	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	6.4	CHEMBL5699	Homo sapiens	Kd	nM	6.4
	7573916	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	400.0	CHEMBL5699	Homo sapiens	Kd	nM	400.0
	7574961	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	280.0	CHEMBL5699	Homo sapiens	Kd	nM	280.0
	7575422	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	2600.0	CHEMBL5699	Homo sapiens	Kd	nM	2600.0
	7575893	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7575916	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	560.0	CHEMBL5699	Homo sapiens	Kd	nM	560.0
	7576324	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7576935	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7577394	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	640.0	CHEMBL5699	Homo sapiens	Kd	nM	640.0
	7577900	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	1900.0	CHEMBL5699	Homo sapiens	Kd	nM	1900.0
	7578305	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	98.0	CHEMBL5699	Homo sapiens	Kd	nM	98.0
	7578943	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7579317	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7579799	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	560.0	CHEMBL5699	Homo sapiens	Kd	nM	560.0
	7580268	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	520.0	CHEMBL5699	Homo sapiens	Kd	nM	520.0
	7580671	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	430.0	CHEMBL5699	Homo sapiens	Kd	nM	430.0
	7581301	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7581689	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7582160	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7582624	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7583024	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1700.0	CHEMBL5699	Homo sapiens	Kd	nM	1700.0
	7583602	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7584047	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7584518	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7584980	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	78.0	CHEMBL5699	Homo sapiens	Kd	nM	78.0
	7585384	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7585535	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7585943	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7586389	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7586860	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7587314	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7587496	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7587915	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7588368	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	2100.0	CHEMBL5699	Homo sapiens	Kd	nM	2100.0
	7588839	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7589290	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7589461	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7589885	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	15.0	CHEMBL5699	Homo sapiens	Kd	nM	15.0
	7590352	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7590826	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7591434	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7591856	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	3700.0	CHEMBL5699	Homo sapiens	Kd	nM	3700.0
	7592328	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7592812	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7593401	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7593836	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7594308	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	6900.0	CHEMBL5699	Homo sapiens	Kd	nM	6900.0
	7594339	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7594791	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	29.0	CHEMBL5699	Homo sapiens	Kd	nM	29.0
	7595369	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7595813	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	4900.0	CHEMBL5699	Homo sapiens	Kd	nM	4900.0
	7596316	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7596763	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7597341	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7597825	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5699	Homo sapiens	Kd	nM	10000.0
	7598295	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	7300.0	CHEMBL5699	Homo sapiens	Kd	nM	7300.0
	7598737	CHEMBL1908792	Binding constant for SIK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1.1	CHEMBL5699	Homo sapiens	Kd	nM	1.1
	8061282	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.81	CHEMBL5699	Homo sapiens	Inhibition	%	-0.81
	8061459	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O	Outside typical range	CHEMBL1789962	=	Inhibition	%	-13.78	CHEMBL5699	Homo sapiens	Inhibition	%	-13.78
	8061790	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	22.86	CHEMBL5699	Homo sapiens	Inhibition	%	22.86
	8061981	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.86	CHEMBL5699	Homo sapiens	Inhibition	%	2.86
	8062321	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	5.17	CHEMBL5699	Homo sapiens	Inhibition	%	5.17
	8062483	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	9.87	CHEMBL5699	Homo sapiens	Inhibition	%	9.87
	8062707	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	3.09	CHEMBL5699	Homo sapiens	Inhibition	%	3.09
	8062805	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	3.95	CHEMBL5699	Homo sapiens	Inhibition	%	3.95
	8063029	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.41	CHEMBL5699	Homo sapiens	Inhibition	%	-0.41
	8063161	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	8.19	CHEMBL5699	Homo sapiens	Inhibition	%	8.19
	8063328	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	5.44	CHEMBL5699	Homo sapiens	Inhibition	%	5.44
	8063552	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.72	CHEMBL5699	Homo sapiens	Inhibition	%	1.72
	8063660	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	7.51	CHEMBL5699	Homo sapiens	Inhibition	%	7.51
	8063842	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	4.37	CHEMBL5699	Homo sapiens	Inhibition	%	4.37
	8064066	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	3.42	CHEMBL5699	Homo sapiens	Inhibition	%	3.42
	8064181	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	-0.26	CHEMBL5699	Homo sapiens	Inhibition	%	-0.26
	8064615	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	10.12	CHEMBL5699	Homo sapiens	Inhibition	%	10.12
	8064753	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	1.69	CHEMBL5699	Homo sapiens	Inhibition	%	1.69
	8065143	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.86	CHEMBL5699	Homo sapiens	Inhibition	%	2.86
	8065259	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	11.58	CHEMBL5699	Homo sapiens	Inhibition	%	11.58
	8065483	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	-0.32	CHEMBL5699	Homo sapiens	Inhibition	%	-0.32
	8065658	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	6.02	CHEMBL5699	Homo sapiens	Inhibition	%	6.02
	8065773	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	4.79	CHEMBL5699	Homo sapiens	Inhibition	%	4.79
	8065997	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	4.74	CHEMBL5699	Homo sapiens	Inhibition	%	4.74
	8066207	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-4.39	CHEMBL5699	Homo sapiens	Inhibition	%	-4.39
	8066343	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	39.0	CHEMBL5699	Homo sapiens	Inhibition	%	39.0
	8066567	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	3.15	CHEMBL5699	Homo sapiens	Inhibition	%	3.15
	8066733	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	6.15	CHEMBL5699	Homo sapiens	Inhibition	%	6.15
	8067081	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	7.96	CHEMBL5699	Homo sapiens	Inhibition	%	7.96
	8067256	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.97	CHEMBL5699	Homo sapiens	Inhibition	%	0.97
	8067601	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.0	CHEMBL5699	Homo sapiens	Inhibition	%	0.0
	8067811	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	6.79	CHEMBL5699	Homo sapiens	Inhibition	%	6.79
	8068170	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	39.15	CHEMBL5699	Homo sapiens	Inhibition	%	39.15
	8068334	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.76	CHEMBL5699	Homo sapiens	Inhibition	%	1.76
	8068683	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-1.57	CHEMBL5699	Homo sapiens	Inhibition	%	-1.57
	8068857	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.1	CHEMBL5699	Homo sapiens	Inhibition	%	0.1
	8069206	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	14.9	CHEMBL5699	Homo sapiens	Inhibition	%	14.9
	8069501	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	12.91	CHEMBL5699	Homo sapiens	Inhibition	%	12.91
	8069662	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	4.74	CHEMBL5699	Homo sapiens	Inhibition	%	4.74
	8069886	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	5.46	CHEMBL5699	Homo sapiens	Inhibition	%	5.46
	8070012	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	8.23	CHEMBL5699	Homo sapiens	Inhibition	%	8.23
	8070184	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.52	CHEMBL5699	Homo sapiens	Inhibition	%	0.52
	8070408	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	5.27	CHEMBL5699	Homo sapiens	Inhibition	%	5.27
	8070533	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-2.6	CHEMBL5699	Homo sapiens	Inhibition	%	-2.6
	8070831	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	47.08	CHEMBL5699	Homo sapiens	Inhibition	%	47.08
	8071212	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	-2.05	CHEMBL5699	Homo sapiens	Inhibition	%	-2.05
	8071338	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	3.18	CHEMBL5699	Homo sapiens	Inhibition	%	3.18
	8071735	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.56	CHEMBL5699	Homo sapiens	Inhibition	%	3.56
	8071860	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-1.02	CHEMBL5699	Homo sapiens	Inhibition	%	-1.02
	8072084	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.97	CHEMBL5699	Homo sapiens	Inhibition	%	0.97
	8072174	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.54	CHEMBL5699	Homo sapiens	Inhibition	%	-0.54
	8072555	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.28	CHEMBL5699	Homo sapiens	Inhibition	%	1.28
	8072680	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	13.78	CHEMBL5699	Homo sapiens	Inhibition	%	13.78
	8072904	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	4.39	CHEMBL5699	Homo sapiens	Inhibition	%	4.39
	8073071	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	5.0	CHEMBL5699	Homo sapiens	Inhibition	%	5.0
	8073420	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-6.65	CHEMBL5699	Homo sapiens	Inhibition	%	-6.65
	8073539	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-5.87	CHEMBL5699	Homo sapiens	Inhibition	%	-5.87
	8073763	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	10.43	CHEMBL5699	Homo sapiens	Inhibition	%	10.43
	8073772	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	3.76	CHEMBL5699	Homo sapiens	Inhibition	%	3.76
	8073996	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-6.78	CHEMBL5699	Homo sapiens	Inhibition	%	-6.78
	8074148	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	9.23	CHEMBL5699	Homo sapiens	Inhibition	%	9.23
	8074502	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	9.54	CHEMBL5699	Homo sapiens	Inhibition	%	9.54
	8074659	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.81	CHEMBL5699	Homo sapiens	Inhibition	%	3.81
	8075010	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-4.22	CHEMBL5699	Homo sapiens	Inhibition	%	-4.22
	8075345	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-2.31	CHEMBL5699	Homo sapiens	Inhibition	%	-2.31
	8075582	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-1.41	CHEMBL5699	Homo sapiens	Inhibition	%	-1.41
	8075723	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	10.69	CHEMBL5699	Homo sapiens	Inhibition	%	10.69
	8076089	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	4.06	CHEMBL5699	Homo sapiens	Inhibition	%	4.06
	8076237	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	-3.54	CHEMBL5699	Homo sapiens	Inhibition	%	-3.54
	8076461	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.23	CHEMBL5699	Homo sapiens	Inhibition	%	1.23
	8076595	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	3.12	CHEMBL5699	Homo sapiens	Inhibition	%	3.12
	8076921	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.48	CHEMBL5699	Homo sapiens	Inhibition	%	2.48
	8077168	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-0.81	CHEMBL5699	Homo sapiens	Inhibition	%	-0.81
	8077296	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	4.62	CHEMBL5699	Homo sapiens	Inhibition	%	4.62
	8077520	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.14	CHEMBL5699	Homo sapiens	Inhibition	%	4.14
	8077671	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	5.38	CHEMBL5699	Homo sapiens	Inhibition	%	5.38
	8078038	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	3.75	CHEMBL5699	Homo sapiens	Inhibition	%	3.75
	8078177	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-6.2	CHEMBL5699	Homo sapiens	Inhibition	%	-6.2
	8078503	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-6.05	CHEMBL5699	Homo sapiens	Inhibition	%	-6.05
	8078753	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	14.82	CHEMBL5699	Homo sapiens	Inhibition	%	14.82
	8079093	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	3.76	CHEMBL5699	Homo sapiens	Inhibition	%	3.76
	8079251	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	4.2	CHEMBL5699	Homo sapiens	Inhibition	%	4.2
	8079617	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.09	CHEMBL5699	Homo sapiens	Inhibition	%	3.09
	8079756	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	8.46	CHEMBL5699	Homo sapiens	Inhibition	%	8.46
	8079980	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	10.88	CHEMBL5699	Homo sapiens	Inhibition	%	10.88
	8080085	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	3.25	CHEMBL5699	Homo sapiens	Inhibition	%	3.25
	8080337	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	4.76	CHEMBL5699	Homo sapiens	Inhibition	%	4.76
	8080676	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	3.18	CHEMBL5699	Homo sapiens	Inhibition	%	3.18
	8080840	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	10.59	CHEMBL5699	Homo sapiens	Inhibition	%	10.59
	8081064	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.69	CHEMBL5699	Homo sapiens	Inhibition	%	-0.69
	8081199	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	5.38	CHEMBL5699	Homo sapiens	Inhibition	%	5.38
	8081567	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	11.69	CHEMBL5699	Homo sapiens	Inhibition	%	11.69
	8081670	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-3.06	CHEMBL5699	Homo sapiens	Inhibition	%	-3.06
	8081894	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	19.82	CHEMBL5699	Homo sapiens	Inhibition	%	19.82
	8081922	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	39.66	CHEMBL5699	Homo sapiens	Inhibition	%	39.66
	8082146	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-6.25	CHEMBL5699	Homo sapiens	Inhibition	%	-6.25
	8082259	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	3.43	CHEMBL5699	Homo sapiens	Inhibition	%	3.43
	8082656	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	37.41	CHEMBL5699	Homo sapiens	Inhibition	%	37.41
	8082779	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.33	CHEMBL5699	Homo sapiens	Inhibition	%	1.33
	8083003	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.45	CHEMBL5699	Homo sapiens	Inhibition	%	0.45
	8083159	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	9.61	CHEMBL5699	Homo sapiens	Inhibition	%	9.61
	8083482	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-2.65	CHEMBL5699	Homo sapiens	Inhibition	%	-2.65
	8083736	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	9.23	CHEMBL5699	Homo sapiens	Inhibition	%	9.23
	8083846	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	7.38	CHEMBL5699	Homo sapiens	Inhibition	%	7.38
	8084070	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	21.95	CHEMBL5699	Homo sapiens	Inhibition	%	21.95
	8084255	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	-0.54	CHEMBL5699	Homo sapiens	Inhibition	%	-0.54
	8084597	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.41	CHEMBL5699	Homo sapiens	Inhibition	%	2.41
	8084758	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	12.67	CHEMBL5699	Homo sapiens	Inhibition	%	12.67
	8085080	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	9.32	CHEMBL5699	Homo sapiens	Inhibition	%	9.32
	8085336	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-6.0	CHEMBL5699	Homo sapiens	Inhibition	%	-6.0
	8085668	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	7.17	CHEMBL5699	Homo sapiens	Inhibition	%	7.17
	8085857	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	31.63	CHEMBL5699	Homo sapiens	Inhibition	%	31.63
	8086196	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	4.92	CHEMBL5699	Homo sapiens	Inhibition	%	4.92
	8086358	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	7.89	CHEMBL5699	Homo sapiens	Inhibition	%	7.89
	8086681	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	5.56	CHEMBL5699	Homo sapiens	Inhibition	%	5.56
	8086892	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	2.71	CHEMBL5699	Homo sapiens	Inhibition	%	2.71
	8087116	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	17.32	CHEMBL5699	Homo sapiens	Inhibition	%	17.32
	8087274	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	4.06	CHEMBL5699	Homo sapiens	Inhibition	%	4.06
	8087612	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	1.94	CHEMBL5699	Homo sapiens	Inhibition	%	1.94
	8087750	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.94	CHEMBL5699	Homo sapiens	Inhibition	%	1.94
	8088116	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	6.58	CHEMBL5699	Homo sapiens	Inhibition	%	6.58
	8088264	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-1.02	CHEMBL5699	Homo sapiens	Inhibition	%	-1.02
	8088488	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	3.58	CHEMBL5699	Homo sapiens	Inhibition	%	3.58
	8088616	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	2.99	CHEMBL5699	Homo sapiens	Inhibition	%	2.99
	8088933	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.28	CHEMBL5699	Homo sapiens	Inhibition	%	1.28
	8089061	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.16	CHEMBL5699	Homo sapiens	Inhibition	%	-0.16
	8089285	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.62	CHEMBL5699	Homo sapiens	Inhibition	%	-0.62
	8089433	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	4.69	CHEMBL5699	Homo sapiens	Inhibition	%	4.69
	8089777	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.64	CHEMBL5699	Homo sapiens	Inhibition	%	1.64
	8089957	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-1.57	CHEMBL5699	Homo sapiens	Inhibition	%	-1.57
	8090346	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.18	CHEMBL5699	Homo sapiens	Inhibition	%	0.18
	8090513	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	-0.49	CHEMBL5699	Homo sapiens	Inhibition	%	-0.49
	8090876	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	0.98	CHEMBL5699	Homo sapiens	Inhibition	%	0.98
	8091081	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.65	CHEMBL5699	Homo sapiens	Inhibition	%	3.65
	8091442	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	2.87	CHEMBL5699	Homo sapiens	Inhibition	%	2.87
	8091597	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	6.63	CHEMBL5699	Homo sapiens	Inhibition	%	6.63
	8091937	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	5.2	CHEMBL5699	Homo sapiens	Inhibition	%	5.2
	8092074	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-0.18	CHEMBL5699	Homo sapiens	Inhibition	%	-0.18
	8092298	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	7.64	CHEMBL5699	Homo sapiens	Inhibition	%	7.64
	8092449	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	7.98	CHEMBL5699	Homo sapiens	Inhibition	%	7.98
	8092821	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.25	CHEMBL5699	Homo sapiens	Inhibition	%	2.25
	8092950	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	12.04	CHEMBL5699	Homo sapiens	Inhibition	%	12.04
	8093262	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	7.07	CHEMBL5699	Homo sapiens	Inhibition	%	7.07
	8093626	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-1.91	CHEMBL5699	Homo sapiens	Inhibition	%	-1.91
	8093765	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	15.52	CHEMBL5699	Homo sapiens	Inhibition	%	15.52
	8094109	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	3.21	CHEMBL5699	Homo sapiens	Inhibition	%	3.21
	8094289	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-2.65	CHEMBL5699	Homo sapiens	Inhibition	%	-2.65
	8094513	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.13	CHEMBL5699	Homo sapiens	Inhibition	%	0.13
	8094688	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	3.18	CHEMBL5699	Homo sapiens	Inhibition	%	3.18
	8094844	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	4.81	CHEMBL5699	Homo sapiens	Inhibition	%	4.81
	8095208	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-0.49	CHEMBL5699	Homo sapiens	Inhibition	%	-0.49
	8095411	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	6.41	CHEMBL5699	Homo sapiens	Inhibition	%	6.41
	8095776	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	8.52	CHEMBL5699	Homo sapiens	Inhibition	%	8.52
	8095924	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	4.37	CHEMBL5699	Homo sapiens	Inhibition	%	4.37
	8096148	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	3.7	CHEMBL5699	Homo sapiens	Inhibition	%	3.7
	8096265	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.99	CHEMBL5699	Homo sapiens	Inhibition	%	4.99
	8096628	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.44	CHEMBL5699	Homo sapiens	Inhibition	%	1.44
	8096784	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	0.61	CHEMBL5699	Homo sapiens	Inhibition	%	0.61
	8097155	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-2.41	CHEMBL5699	Homo sapiens	Inhibition	%	-2.41
	8097462	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	16.92	CHEMBL5699	Homo sapiens	Inhibition	%	16.92
	8097836	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.75	CHEMBL5699	Homo sapiens	Inhibition	%	1.75
	8097969	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-0.04	CHEMBL5699	Homo sapiens	Inhibition	%	-0.04
	8098193	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	2.04	CHEMBL5699	Homo sapiens	Inhibition	%	2.04
	8098313	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.88	CHEMBL5699	Homo sapiens	Inhibition	%	-0.88
	8098717	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-3.82	CHEMBL5699	Homo sapiens	Inhibition	%	-3.82
	8098902	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	8.56	CHEMBL5699	Homo sapiens	Inhibition	%	8.56
	8099046	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	-0.18	CHEMBL5699	Homo sapiens	Inhibition	%	-0.18
	8099270	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	5.7	CHEMBL5699	Homo sapiens	Inhibition	%	5.7
	8099412	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	-0.99	CHEMBL5699	Homo sapiens	Inhibition	%	-0.99
	8099606	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	24.15	CHEMBL5699	Homo sapiens	Inhibition	%	24.15
	8099830	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	68.9	CHEMBL5699	Homo sapiens	Inhibition	%	68.9
	8099977	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	8.99	CHEMBL5699	Homo sapiens	Inhibition	%	8.99
	8100347	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-1.16	CHEMBL5699	Homo sapiens	Inhibition	%	-1.16
	8100463	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	9.11	CHEMBL5699	Homo sapiens	Inhibition	%	9.11
	8100687	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.82	CHEMBL5699	Homo sapiens	Inhibition	%	2.82
	8100827	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	5.75	CHEMBL5699	Homo sapiens	Inhibition	%	5.75
	8100987	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.27	CHEMBL5699	Homo sapiens	Inhibition	%	3.27
	8101211	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.53	CHEMBL5699	Homo sapiens	Inhibition	%	4.53
	8101353	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	3.12	CHEMBL5699	Homo sapiens	Inhibition	%	3.12
	8101538	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.04	CHEMBL5699	Homo sapiens	Inhibition	%	2.04
	8101762	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.17	CHEMBL5699	Homo sapiens	Inhibition	%	0.17
	8101791	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	28.62	CHEMBL5699	Homo sapiens	Inhibition	%	28.62
	8102015	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	67.41	CHEMBL5699	Homo sapiens	Inhibition	%	67.41
	8102170	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-4.28	CHEMBL5699	Homo sapiens	Inhibition	%	-4.28
	8102525	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	3.3	CHEMBL5699	Homo sapiens	Inhibition	%	3.3
	8102645	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-4.75	CHEMBL5699	Homo sapiens	Inhibition	%	-4.75
	8102869	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-4.91	CHEMBL5699	Homo sapiens	Inhibition	%	-4.91
	8103047	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.35	CHEMBL5699	Homo sapiens	Inhibition	%	1.35
	8103243	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.31	CHEMBL5699	Homo sapiens	Inhibition	%	1.31
	8103605	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	7.47	CHEMBL5699	Homo sapiens	Inhibition	%	7.47
	8103755	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	7.06	CHEMBL5699	Homo sapiens	Inhibition	%	7.06
	8104164	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.4	CHEMBL5699	Homo sapiens	Inhibition	%	0.4
	8104312	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	14.69	CHEMBL5699	Homo sapiens	Inhibition	%	14.69
	8104682	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	7.34	CHEMBL5699	Homo sapiens	Inhibition	%	7.34
	8105020	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	9.93	CHEMBL5699	Homo sapiens	Inhibition	%	9.93
	8105160	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.28	CHEMBL5699	Homo sapiens	Inhibition	%	-0.28
	8105550	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	6.72	CHEMBL5699	Homo sapiens	Inhibition	%	6.72
	8105688	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	30.6	CHEMBL5699	Homo sapiens	Inhibition	%	30.6
	8105968	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.42	CHEMBL5699	Homo sapiens	Inhibition	%	1.42
	8106357	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-1.0	CHEMBL5699	Homo sapiens	Inhibition	%	-1.0
	8106513	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	32.5	CHEMBL5699	Homo sapiens	Inhibition	%	32.5
	8106866	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	2.83	CHEMBL5699	Homo sapiens	Inhibition	%	2.83
	8107211	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.71	CHEMBL5699	Homo sapiens	Inhibition	%	-0.71
	8107383	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-0.18	CHEMBL5699	Homo sapiens	Inhibition	%	-0.18
	8107584	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	-1.51	CHEMBL5699	Homo sapiens	Inhibition	%	-1.51
	8107808	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	-1.34	CHEMBL5699	Homo sapiens	Inhibition	%	-1.34
	8107943	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	25.05	CHEMBL5699	Homo sapiens	Inhibition	%	25.05
	8108101	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	7.24	CHEMBL5699	Homo sapiens	Inhibition	%	7.24
	8108325	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	8.75	CHEMBL5699	Homo sapiens	Inhibition	%	8.75
	8108500	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	1.86	CHEMBL5699	Homo sapiens	Inhibition	%	1.86
	8108647	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	7.32	CHEMBL5699	Homo sapiens	Inhibition	%	7.32
	8108871	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	21.98	CHEMBL5699	Homo sapiens	Inhibition	%	21.98
	8109013	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.88	CHEMBL5699	Homo sapiens	Inhibition	%	0.88
	8109351	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	7.26	CHEMBL5699	Homo sapiens	Inhibition	%	7.26
	8109481	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.03	CHEMBL5699	Homo sapiens	Inhibition	%	-0.03
	8109705	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-8.81	CHEMBL5699	Homo sapiens	Inhibition	%	-8.81
	8109876	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	14.04	CHEMBL5699	Homo sapiens	Inhibition	%	14.04
	8110008	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	7.38	CHEMBL5699	Homo sapiens	Inhibition	%	7.38
	8110232	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	33.81	CHEMBL5699	Homo sapiens	Inhibition	%	33.81
	8110287	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.44	CHEMBL5699	Homo sapiens	Inhibition	%	1.44
	8110511	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.73	CHEMBL5699	Homo sapiens	Inhibition	%	2.73
	8110677	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	6.81	CHEMBL5699	Homo sapiens	Inhibition	%	6.81
	8110835	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-2.87	CHEMBL5699	Homo sapiens	Inhibition	%	-2.87
	8111059	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-1.04	CHEMBL5699	Homo sapiens	Inhibition	%	-1.04
	8111182	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.99	CHEMBL5699	Homo sapiens	Inhibition	%	1.99
	8111533	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-4.09	CHEMBL5699	Homo sapiens	Inhibition	%	-4.09
	8111699	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	3.79	CHEMBL5699	Homo sapiens	Inhibition	%	3.79
	8112128	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	9.41	CHEMBL5699	Homo sapiens	Inhibition	%	9.41
	8112265	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.4	CHEMBL5699	Homo sapiens	Inhibition	%	0.4
	8112657	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	9.17	CHEMBL5699	Homo sapiens	Inhibition	%	9.17
	8112829	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.71	CHEMBL5699	Homo sapiens	Inhibition	%	-0.71
	8113205	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.14	CHEMBL5699	Homo sapiens	Inhibition	%	3.14
	8113341	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.15	CHEMBL5699	Homo sapiens	Inhibition	%	1.15
	8113689	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	12.55	CHEMBL5699	Homo sapiens	Inhibition	%	12.55
	8114029	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-5.47	CHEMBL5699	Homo sapiens	Inhibition	%	-5.47
	8114205	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	6.4	CHEMBL5699	Homo sapiens	Inhibition	%	6.4
	8114561	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.95	CHEMBL5699	Homo sapiens	Inhibition	%	3.95
	8114837	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.96	CHEMBL5699	Homo sapiens	Inhibition	%	1.96
	8115003	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	6.29	CHEMBL5699	Homo sapiens	Inhibition	%	6.29
	8115392	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-4.28	CHEMBL5699	Homo sapiens	Inhibition	%	-4.28
	8115512	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.48	CHEMBL5699	Homo sapiens	Inhibition	%	0.48
	8115736	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	3.22	CHEMBL5699	Homo sapiens	Inhibition	%	3.22
	8115869	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	6.59	CHEMBL5699	Homo sapiens	Inhibition	%	6.59
	8116028	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-1.9	CHEMBL5699	Homo sapiens	Inhibition	%	-1.9
	8116252	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	36.05	CHEMBL5699	Homo sapiens	Inhibition	%	36.05
	8116455	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.69	CHEMBL5699	Homo sapiens	Inhibition	%	3.69
	8116589	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.38	CHEMBL5699	Homo sapiens	Inhibition	%	-0.38
	8116813	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	2.29	CHEMBL5699	Homo sapiens	Inhibition	%	2.29
	8116985	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	28.77	CHEMBL5699	Homo sapiens	Inhibition	%	28.77
	8117156	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.59	CHEMBL5699	Homo sapiens	Inhibition	%	-0.59
	8117380	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	2.91	CHEMBL5699	Homo sapiens	Inhibition	%	2.91
	8117538	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	9.54	CHEMBL5699	Homo sapiens	Inhibition	%	9.54
	8117668	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-3.07	CHEMBL5699	Homo sapiens	Inhibition	%	-3.07
	8117892	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-4.01	CHEMBL5699	Homo sapiens	Inhibition	%	-4.01
	8118030	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	0.78	CHEMBL5699	Homo sapiens	Inhibition	%	0.78
	8118370	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	8.28	CHEMBL5699	Homo sapiens	Inhibition	%	8.28
	8118542	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	8.0	CHEMBL5699	Homo sapiens	Inhibition	%	8.0
	8118766	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.38	CHEMBL5699	Homo sapiens	Inhibition	%	4.38
	8118902	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	5.81	CHEMBL5699	Homo sapiens	Inhibition	%	5.81
	8119173	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.18	CHEMBL5699	Homo sapiens	Inhibition	%	0.18
	8119332	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	1.48	CHEMBL5699	Homo sapiens	Inhibition	%	1.48
	8119556	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	7.72	CHEMBL5699	Homo sapiens	Inhibition	%	7.72
	8119723	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.46	CHEMBL5699	Homo sapiens	Inhibition	%	-0.46
	8120066	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.57	CHEMBL5699	Homo sapiens	Inhibition	%	2.57
	8120205	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	10.83	CHEMBL5699	Homo sapiens	Inhibition	%	10.83
	8120589	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-3.57	CHEMBL5699	Homo sapiens	Inhibition	%	-3.57
	8120790	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	14.8	CHEMBL5699	Homo sapiens	Inhibition	%	14.8
	8121142	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	2.16	CHEMBL5699	Homo sapiens	Inhibition	%	2.16
	8121314	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-0.21	CHEMBL5699	Homo sapiens	Inhibition	%	-0.21
	8121705	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-0.94	CHEMBL5699	Homo sapiens	Inhibition	%	-0.94
	8121868	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	3.55	CHEMBL5699	Homo sapiens	Inhibition	%	3.55
	8122213	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-4.61	CHEMBL5699	Homo sapiens	Inhibition	%	-4.61
	8122351	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	8.24	CHEMBL5699	Homo sapiens	Inhibition	%	8.24
	8122575	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	9.0	CHEMBL5699	Homo sapiens	Inhibition	%	9.0
	8122695	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	6.93	CHEMBL5699	Homo sapiens	Inhibition	%	6.93
	8123086	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	10.94	CHEMBL5699	Homo sapiens	Inhibition	%	10.94
	8123228	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	5.82	CHEMBL5699	Homo sapiens	Inhibition	%	5.82
	8123506	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-4.44	CHEMBL5699	Homo sapiens	Inhibition	%	-4.44
	8123880	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	20.35	CHEMBL5699	Homo sapiens	Inhibition	%	20.35
	8124047	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	9.07	CHEMBL5699	Homo sapiens	Inhibition	%	9.07
	8124390	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	4.86	CHEMBL5699	Homo sapiens	Inhibition	%	4.86
	8124529	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.48	CHEMBL5699	Homo sapiens	Inhibition	%	0.48
	8124753	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-0.86	CHEMBL5699	Homo sapiens	Inhibition	%	-0.86
	8124918	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.23	CHEMBL5699	Homo sapiens	Inhibition	%	1.23
	8125119	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.65	CHEMBL5699	Homo sapiens	Inhibition	%	3.65
	8125473	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.86	CHEMBL5699	Homo sapiens	Inhibition	%	1.86
	8125641	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-0.83	CHEMBL5699	Homo sapiens	Inhibition	%	-0.83
	8125865	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-0.9	CHEMBL5699	Homo sapiens	Inhibition	%	-0.9
	8126029	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-2.38	CHEMBL5699	Homo sapiens	Inhibition	%	-2.38
	8126193	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	9.83	CHEMBL5699	Homo sapiens	Inhibition	%	9.83
	8126532	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-6.22	CHEMBL5699	Homo sapiens	Inhibition	%	-6.22
	8126892	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	25.81	CHEMBL5699	Homo sapiens	Inhibition	%	25.81
	8127014	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	6.45	CHEMBL5699	Homo sapiens	Inhibition	%	6.45
	8127405	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	8.6	CHEMBL5699	Homo sapiens	Inhibition	%	8.6
	8127547	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	35.44	CHEMBL5699	Homo sapiens	Inhibition	%	35.44
	8127771	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	4.8	CHEMBL5699	Homo sapiens	Inhibition	%	4.8
	8127835	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.91	CHEMBL5699	Homo sapiens	Inhibition	%	1.91
	8128059	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.43	CHEMBL5699	Homo sapiens	Inhibition	%	0.43
	8128211	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	4.34	CHEMBL5699	Homo sapiens	Inhibition	%	4.34
	8128378	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	34.08	CHEMBL5699	Homo sapiens	Inhibition	%	34.08
	8128602	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	2.24	CHEMBL5699	Homo sapiens	Inhibition	%	2.24
	8128721	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	13.63	CHEMBL5699	Homo sapiens	Inhibition	%	13.63
	8129082	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	5.17	CHEMBL5699	Homo sapiens	Inhibition	%	5.17
	8129253	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-4.64	CHEMBL5699	Homo sapiens	Inhibition	%	-4.64
	8129442	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	19.42	CHEMBL5699	Homo sapiens	Inhibition	%	19.42
	8129666	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	-0.55	CHEMBL5699	Homo sapiens	Inhibition	%	-0.55
	8129805	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-1.67	CHEMBL5699	Homo sapiens	Inhibition	%	-1.67
	8130190	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.27	CHEMBL5699	Homo sapiens	Inhibition	%	0.27
	8130362	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.5	CHEMBL5699	Homo sapiens	Inhibition	%	-0.5
	8130522	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	10.83	CHEMBL5699	Homo sapiens	Inhibition	%	10.83
	8130746	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	47.16	CHEMBL5699	Homo sapiens	Inhibition	%	47.16
	8130862	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.55	CHEMBL5699	Homo sapiens	Inhibition	%	1.55
	8131225	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.38	CHEMBL5699	Homo sapiens	Inhibition	%	4.38
	8131345	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	10.09	CHEMBL5699	Homo sapiens	Inhibition	%	10.09
	8131569	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.1	CHEMBL5699	Homo sapiens	Inhibition	%	1.1
	8131736	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	36.73	CHEMBL5699	Homo sapiens	Inhibition	%	36.73
	8132101	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	3.6	CHEMBL5699	Homo sapiens	Inhibition	%	3.6
	8132387	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	4.5	CHEMBL5699	Homo sapiens	Inhibition	%	4.5
	8132534	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	4.27	CHEMBL5699	Homo sapiens	Inhibition	%	4.27
	8132926	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	8.3	CHEMBL5699	Homo sapiens	Inhibition	%	8.3
	8133047	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	4.14	CHEMBL5699	Homo sapiens	Inhibition	%	4.14
	8133409	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	-1.82	CHEMBL5699	Homo sapiens	Inhibition	%	-1.82
	8133581	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.24	CHEMBL5699	Homo sapiens	Inhibition	%	-1.24
	8133985	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	17.45	CHEMBL5699	Homo sapiens	Inhibition	%	17.45
	8134133	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	5.43	CHEMBL5699	Homo sapiens	Inhibition	%	5.43
	8134517	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	5.39	CHEMBL5699	Homo sapiens	Inhibition	%	5.39
	8134701	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	4.05	CHEMBL5699	Homo sapiens	Inhibition	%	4.05
	8135085	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	5.34	CHEMBL5699	Homo sapiens	Inhibition	%	5.34
	8135200	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.8	CHEMBL5699	Homo sapiens	Inhibition	%	4.8
	8135424	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.8	CHEMBL5699	Homo sapiens	Inhibition	%	4.8
	8135565	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	13.59	CHEMBL5699	Homo sapiens	Inhibition	%	13.59
	8135910	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	8.54	CHEMBL5699	Homo sapiens	Inhibition	%	8.54
	8136078	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	5.87	CHEMBL5699	Homo sapiens	Inhibition	%	5.87
	8136446	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	2.25	CHEMBL5699	Homo sapiens	Inhibition	%	2.25
	8136736	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	2.04	CHEMBL5699	Homo sapiens	Inhibition	%	2.04
	8136871	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-0.93	CHEMBL5699	Homo sapiens	Inhibition	%	-0.93
	8137095	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	2.87	CHEMBL5699	Homo sapiens	Inhibition	%	2.87
	8137258	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	-0.68	CHEMBL5699	Homo sapiens	Inhibition	%	-0.68
	8137378	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.45	CHEMBL5699	Homo sapiens	Inhibition	%	0.45
	8137602	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	7.18	CHEMBL5699	Homo sapiens	Inhibition	%	7.18
	8137750	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.81	CHEMBL5699	Homo sapiens	Inhibition	%	1.81
	8137916	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.07	CHEMBL5699	Homo sapiens	Inhibition	%	-2.07
	8138140	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.94	CHEMBL5699	Homo sapiens	Inhibition	%	-0.94
	8138319	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.04	CHEMBL5699	Homo sapiens	Inhibition	%	1.04
	8138467	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	7.33	CHEMBL5699	Homo sapiens	Inhibition	%	7.33
	8138691	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.37	CHEMBL5699	Homo sapiens	Inhibition	%	0.37
	8138849	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	5.33	CHEMBL5699	Homo sapiens	Inhibition	%	5.33
	8139034	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-6.11	CHEMBL5699	Homo sapiens	Inhibition	%	-6.11
	8139258	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.92	CHEMBL5699	Homo sapiens	Inhibition	%	4.92
	8139417	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	21.52	CHEMBL5699	Homo sapiens	Inhibition	%	21.52
	8139755	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.29	CHEMBL5699	Homo sapiens	Inhibition	%	2.29
	8139896	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	8.92	CHEMBL5699	Homo sapiens	Inhibition	%	8.92
	8140243	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	0.04	CHEMBL5699	Homo sapiens	Inhibition	%	0.04
	8140402	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	6.63	CHEMBL5699	Homo sapiens	Inhibition	%	6.63
	8140626	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.18	CHEMBL5699	Homo sapiens	Inhibition	%	3.18
	8140769	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	18.5	CHEMBL5699	Homo sapiens	Inhibition	%	18.5
	8141071	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.51	CHEMBL5699	Homo sapiens	Inhibition	%	2.51
	8141425	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.98	CHEMBL5699	Homo sapiens	Inhibition	%	0.98
	8141585	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	21.13	CHEMBL5699	Homo sapiens	Inhibition	%	21.13
	8141928	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	27.56	CHEMBL5699	Homo sapiens	Inhibition	%	27.56
	8142089	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.55	CHEMBL5699	Homo sapiens	Inhibition	%	-0.55
	8142481	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	6.88	CHEMBL5699	Homo sapiens	Inhibition	%	6.88
	8142657	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.49	CHEMBL5699	Homo sapiens	Inhibition	%	2.49
	8143030	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-9.28	CHEMBL5699	Homo sapiens	Inhibition	%	-9.28
	8143185	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	-0.99	CHEMBL5699	Homo sapiens	Inhibition	%	-0.99
	8143596	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	9.04	CHEMBL5699	Homo sapiens	Inhibition	%	9.04
	8143755	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	1.03	CHEMBL5699	Homo sapiens	Inhibition	%	1.03
	8144093	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	4.6	CHEMBL5699	Homo sapiens	Inhibition	%	4.6
	8144232	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	10.39	CHEMBL5699	Homo sapiens	Inhibition	%	10.39
	8144456	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	6.78	CHEMBL5699	Homo sapiens	Inhibition	%	6.78
	8144586	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	8.52	CHEMBL5699	Homo sapiens	Inhibition	%	8.52
	8144963	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	5.07	CHEMBL5699	Homo sapiens	Inhibition	%	5.07
	8145100	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.1	CHEMBL5699	Homo sapiens	Inhibition	%	2.1
	8145413	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	-3.15	CHEMBL5699	Homo sapiens	Inhibition	%	-3.15
	8145761	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	3.32	CHEMBL5699	Homo sapiens	Inhibition	%	3.32
	8145922	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	9.6	CHEMBL5699	Homo sapiens	Inhibition	%	9.6
	8146266	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	4.86	CHEMBL5699	Homo sapiens	Inhibition	%	4.86
	8146426	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	6.1	CHEMBL5699	Homo sapiens	Inhibition	%	6.1
	8146650	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-2.92	CHEMBL5699	Homo sapiens	Inhibition	%	-2.92
	8146817	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	30.31	CHEMBL5699	Homo sapiens	Inhibition	%	30.31
	8146986	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	-2.04	CHEMBL5699	Homo sapiens	Inhibition	%	-2.04
	8147210	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	5.33	CHEMBL5699	Homo sapiens	Inhibition	%	5.33
	8147352	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.43	CHEMBL5699	Homo sapiens	Inhibition	%	2.43
	8147505	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	5.08	CHEMBL5699	Homo sapiens	Inhibition	%	5.08
	8147729	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	4.76	CHEMBL5699	Homo sapiens	Inhibition	%	4.76
	8147916	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	3.66	CHEMBL5699	Homo sapiens	Inhibition	%	3.66
	8148074	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	9.81	CHEMBL5699	Homo sapiens	Inhibition	%	9.81
	8148298	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	7.32	CHEMBL5699	Homo sapiens	Inhibition	%	7.32
	8148412	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	4.18	CHEMBL5699	Homo sapiens	Inhibition	%	4.18
	8148775	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	15.86	CHEMBL5699	Homo sapiens	Inhibition	%	15.86
	8148913	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	7.22	CHEMBL5699	Homo sapiens	Inhibition	%	7.22
	8149137	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.63	CHEMBL5699	Homo sapiens	Inhibition	%	3.63
	8149296	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.11	CHEMBL5699	Homo sapiens	Inhibition	%	1.11
	8149430	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	6.58	CHEMBL5699	Homo sapiens	Inhibition	%	6.58
	8149654	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	2.51	CHEMBL5699	Homo sapiens	Inhibition	%	2.51
	8149752	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	7.72	CHEMBL5699	Homo sapiens	Inhibition	%	7.72
	8149976	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	30.43	CHEMBL5699	Homo sapiens	Inhibition	%	30.43
	8150101	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-4.88	CHEMBL5699	Homo sapiens	Inhibition	%	-4.88
	8150261	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	10.16	CHEMBL5699	Homo sapiens	Inhibition	%	10.16
	8150485	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-1.57	CHEMBL5699	Homo sapiens	Inhibition	%	-1.57
	8150605	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.47	CHEMBL5699	Homo sapiens	Inhibition	%	0.47
	8150994	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	5.93	CHEMBL5699	Homo sapiens	Inhibition	%	5.93
	8151157	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.95	CHEMBL5699	Homo sapiens	Inhibition	%	-3.95
	8151558	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.42	CHEMBL5699	Homo sapiens	Inhibition	%	0.42
	8151696	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	5.47	CHEMBL5699	Homo sapiens	Inhibition	%	5.47
	8152074	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	8.4	CHEMBL5699	Homo sapiens	Inhibition	%	8.4
	8152262	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	9.93	CHEMBL5699	Homo sapiens	Inhibition	%	9.93
	8152644	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	13.76	CHEMBL5699	Homo sapiens	Inhibition	%	13.76
	8152758	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	-0.54	CHEMBL5699	Homo sapiens	Inhibition	%	-0.54
	8152982	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	7.47	CHEMBL5699	Homo sapiens	Inhibition	%	7.47
	8153121	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.15	CHEMBL5699	Homo sapiens	Inhibition	%	2.15
	8153482	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	6.0	CHEMBL5699	Homo sapiens	Inhibition	%	6.0
	8153639	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.48	CHEMBL5699	Homo sapiens	Inhibition	%	0.48
	8153996	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	6.02	CHEMBL5699	Homo sapiens	Inhibition	%	6.02
	8154317	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	9.3	CHEMBL5699	Homo sapiens	Inhibition	%	9.3
	8154443	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.5	CHEMBL5699	Homo sapiens	Inhibition	%	0.5
	8154826	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-1.75	CHEMBL5699	Homo sapiens	Inhibition	%	-1.75
	8154946	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.81	CHEMBL5699	Homo sapiens	Inhibition	%	0.81
	8155170	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.17	CHEMBL5699	Homo sapiens	Inhibition	%	0.17
	8155346	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-1.04	CHEMBL5699	Homo sapiens	Inhibition	%	-1.04
	8155507	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-7.9	CHEMBL5699	Homo sapiens	Inhibition	%	-7.9
	8155731	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.09	CHEMBL5699	Homo sapiens	Inhibition	%	3.09
	8155909	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.21	CHEMBL5699	Homo sapiens	Inhibition	%	2.21
	8156047	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.86	CHEMBL5699	Homo sapiens	Inhibition	%	2.86
	8156271	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.43	CHEMBL5699	Homo sapiens	Inhibition	%	3.43
	8156483	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	-1.22	CHEMBL5699	Homo sapiens	Inhibition	%	-1.22
	8156633	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	14.01	CHEMBL5699	Homo sapiens	Inhibition	%	14.01
	8157000	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	18.86	CHEMBL5699	Homo sapiens	Inhibition	%	18.86
	8157344	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	0.64	CHEMBL5699	Homo sapiens	Inhibition	%	0.64
	8157485	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	10.88	CHEMBL5699	Homo sapiens	Inhibition	%	10.88
	8157839	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	7.72	CHEMBL5699	Homo sapiens	Inhibition	%	7.72
	8158000	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-1.07	CHEMBL5699	Homo sapiens	Inhibition	%	-1.07
	8158224	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-2.3	CHEMBL5699	Homo sapiens	Inhibition	%	-2.3
	8158250	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	10.8	CHEMBL5699	Homo sapiens	Inhibition	%	10.8
	8158474	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	4.34	CHEMBL5699	Homo sapiens	Inhibition	%	4.34
	8158632	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	8.6	CHEMBL5699	Homo sapiens	Inhibition	%	8.6
	8158801	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	10.88	CHEMBL5699	Homo sapiens	Inhibition	%	10.88
	8159025	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	21.92	CHEMBL5699	Homo sapiens	Inhibition	%	21.92
	8159160	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	8.56	CHEMBL5699	Homo sapiens	Inhibition	%	8.56
	8159504	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	5.11	CHEMBL5699	Homo sapiens	Inhibition	%	5.11
	8159635	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	16.36	CHEMBL5699	Homo sapiens	Inhibition	%	16.36
	8159859	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	2.41	CHEMBL5699	Homo sapiens	Inhibition	%	2.41
	8160000	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	3.1	CHEMBL5699	Homo sapiens	Inhibition	%	3.1
	8160361	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	8.69	CHEMBL5699	Homo sapiens	Inhibition	%	8.69
	8160511	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.25	CHEMBL5699	Homo sapiens	Inhibition	%	-0.25
	8160805	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.33	CHEMBL5699	Homo sapiens	Inhibition	%	3.33
	8160955	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	9.27	CHEMBL5699	Homo sapiens	Inhibition	%	9.27
	8161179	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	11.15	CHEMBL5699	Homo sapiens	Inhibition	%	11.15
	8161322	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	11.07	CHEMBL5699	Homo sapiens	Inhibition	%	11.07
	8161671	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	8.17	CHEMBL5699	Homo sapiens	Inhibition	%	8.17
	8161809	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	13.5	CHEMBL5699	Homo sapiens	Inhibition	%	13.5
	8162033	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	11.71	CHEMBL5699	Homo sapiens	Inhibition	%	11.71
	8162163	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	27.82	CHEMBL5699	Homo sapiens	Inhibition	%	27.82
	8162547	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	0.76	CHEMBL5699	Homo sapiens	Inhibition	%	0.76
	8162800	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	10.11	CHEMBL5699	Homo sapiens	Inhibition	%	10.11
	8162948	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	9.07	CHEMBL5699	Homo sapiens	Inhibition	%	9.07
	8163341	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.47	CHEMBL5699	Homo sapiens	Inhibition	%	2.47
	8163475	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	11.12	CHEMBL5699	Homo sapiens	Inhibition	%	11.12
	8163822	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	5.89	CHEMBL5699	Homo sapiens	Inhibition	%	5.89
	8164180	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	11.04	CHEMBL5699	Homo sapiens	Inhibition	%	11.04
	8164320	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.72	CHEMBL5699	Homo sapiens	Inhibition	%	1.72
	8164699	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	4.44	CHEMBL5699	Homo sapiens	Inhibition	%	4.44
	8164843	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	28.63	CHEMBL5699	Homo sapiens	Inhibition	%	28.63
	8165137	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	3.05	CHEMBL5699	Homo sapiens	Inhibition	%	3.05
	8165502	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	6.42	CHEMBL5699	Homo sapiens	Inhibition	%	6.42
	8165645	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	17.66	CHEMBL5699	Homo sapiens	Inhibition	%	17.66
	8165869	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	3.48	CHEMBL5699	Homo sapiens	Inhibition	%	3.48
	8165995	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	10.71	CHEMBL5699	Homo sapiens	Inhibition	%	10.71
	8166357	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	37.86	CHEMBL5699	Homo sapiens	Inhibition	%	37.86
	8166487	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	4.34	CHEMBL5699	Homo sapiens	Inhibition	%	4.34
	8166812	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	28.01	CHEMBL5699	Homo sapiens	Inhibition	%	28.01
	8167124	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	8.55	CHEMBL5699	Homo sapiens	Inhibition	%	8.55
	8167265	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	40.74	CHEMBL5699	Homo sapiens	Inhibition	%	40.74
	8167489	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	7.71	CHEMBL5699	Homo sapiens	Inhibition	%	7.71
	8167653	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	12.43	CHEMBL5699	Homo sapiens	Inhibition	%	12.43
	8167786	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	7.14	CHEMBL5699	Homo sapiens	Inhibition	%	7.14
	8168010	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	12.51	CHEMBL5699	Homo sapiens	Inhibition	%	12.51
	8168134	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.04	CHEMBL5699	Homo sapiens	Inhibition	%	3.04
	8168499	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	9.22	CHEMBL5699	Homo sapiens	Inhibition	%	9.22
	8168635	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.15	CHEMBL5699	Homo sapiens	Inhibition	%	1.15
	8168859	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.65	CHEMBL5699	Homo sapiens	Inhibition	%	-0.65
	8169023	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	11.94	CHEMBL5699	Homo sapiens	Inhibition	%	11.94
	8169165	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	5.95	CHEMBL5699	Homo sapiens	Inhibition	%	5.95
	8169389	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.37	CHEMBL5699	Homo sapiens	Inhibition	%	1.37
	8169469	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	0.1	CHEMBL5699	Homo sapiens	Inhibition	%	0.1
	8169693	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	6.36	CHEMBL5699	Homo sapiens	Inhibition	%	6.36
	8169827	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	-0.37	CHEMBL5699	Homo sapiens	Inhibition	%	-0.37
	8170196	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	4.42	CHEMBL5699	Homo sapiens	Inhibition	%	4.42
	8170321	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	7.86	CHEMBL5699	Homo sapiens	Inhibition	%	7.86
	8170685	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	3.58	CHEMBL5699	Homo sapiens	Inhibition	%	3.58
	8170820	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	10.25	CHEMBL5699	Homo sapiens	Inhibition	%	10.25
	8171044	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	2.73	CHEMBL5699	Homo sapiens	Inhibition	%	2.73
	8171241	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	4.45	CHEMBL5699	Homo sapiens	Inhibition	%	4.45
	8171458	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	13.8	CHEMBL5699	Homo sapiens	Inhibition	%	13.8
	8171823	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	7.78	CHEMBL5699	Homo sapiens	Inhibition	%	7.78
	8171976	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	5.11	CHEMBL5699	Homo sapiens	Inhibition	%	5.11
	8172332	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	9.13	CHEMBL5699	Homo sapiens	Inhibition	%	9.13
	8172460	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.13	CHEMBL5699	Homo sapiens	Inhibition	%	1.13
	8172684	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.8	CHEMBL5699	Homo sapiens	Inhibition	%	0.8
	8172826	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	40.36	CHEMBL5699	Homo sapiens	Inhibition	%	40.36
	8173186	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-7.23	CHEMBL5699	Homo sapiens	Inhibition	%	-7.23
	8173351	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	15.36	CHEMBL5699	Homo sapiens	Inhibition	%	15.36
	8173716	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	-1.13	CHEMBL5699	Homo sapiens	Inhibition	%	-1.13
	8174027	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	16.95	CHEMBL5699	Homo sapiens	Inhibition	%	16.95
	8174159	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	5.81	CHEMBL5699	Homo sapiens	Inhibition	%	5.81
	8174531	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-1.64	CHEMBL5699	Homo sapiens	Inhibition	%	-1.64
	8174653	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.38	CHEMBL5699	Homo sapiens	Inhibition	%	2.38
	8174877	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	4.37	CHEMBL5699	Homo sapiens	Inhibition	%	4.37
	8175020	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	18.43	CHEMBL5699	Homo sapiens	Inhibition	%	18.43
	8175380	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	11.34	CHEMBL5699	Homo sapiens	Inhibition	%	11.34
	8175636	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	11.57	CHEMBL5699	Homo sapiens	Inhibition	%	11.57
	8175799	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	7.91	CHEMBL5699	Homo sapiens	Inhibition	%	7.91
	8176176	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	5.87	CHEMBL5699	Homo sapiens	Inhibition	%	5.87
	8176325	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	14.38	CHEMBL5699	Homo sapiens	Inhibition	%	14.38
	8176549	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	5.24	CHEMBL5699	Homo sapiens	Inhibition	%	5.24
	8176681	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	17.56	CHEMBL5699	Homo sapiens	Inhibition	%	17.56
	8177035	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	10.0	CHEMBL5699	Homo sapiens	Inhibition	%	10.0
	8177177	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	6.01	CHEMBL5699	Homo sapiens	Inhibition	%	6.01
	8177539	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	56.44	CHEMBL5699	Homo sapiens	Inhibition	%	56.44
	8177703	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	54.05	CHEMBL5699	Homo sapiens	Inhibition	%	54.05
	8177927	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	8.76	CHEMBL5699	Homo sapiens	Inhibition	%	8.76
	8178067	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	-0.16	CHEMBL5699	Homo sapiens	Inhibition	%	-0.16
	8178379	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	11.5	CHEMBL5699	Homo sapiens	Inhibition	%	11.5
	8178506	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	20.01	CHEMBL5699	Homo sapiens	Inhibition	%	20.01
	8178730	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	6.43	CHEMBL5699	Homo sapiens	Inhibition	%	6.43
	8178879	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-0.16	CHEMBL5699	Homo sapiens	Inhibition	%	-0.16
	8179226	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	4.15	CHEMBL5699	Homo sapiens	Inhibition	%	4.15
	8179370	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	6.03	CHEMBL5699	Homo sapiens	Inhibition	%	6.03
	8179731	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	4.14	CHEMBL5699	Homo sapiens	Inhibition	%	4.14
	8179988	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	6.82	CHEMBL5699	Homo sapiens	Inhibition	%	6.82
	8180142	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	24.29	CHEMBL5699	Homo sapiens	Inhibition	%	24.29
	8180366	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	3.89	CHEMBL5699	Homo sapiens	Inhibition	%	3.89
	8180522	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	15.82	CHEMBL5699	Homo sapiens	Inhibition	%	15.82
	8180894	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	18.18	CHEMBL5699	Homo sapiens	Inhibition	%	18.18
	8181027	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	15.8	CHEMBL5699	Homo sapiens	Inhibition	%	15.8
	8181382	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-6.72	CHEMBL5699	Homo sapiens	Inhibition	%	-6.72
	8181522	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	53.66	CHEMBL5699	Homo sapiens	Inhibition	%	53.66
	8181746	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	5.24	CHEMBL5699	Homo sapiens	Inhibition	%	5.24
	8181885	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	78.18	CHEMBL5699	Homo sapiens	Inhibition	%	78.18
	8182272	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	11.62	CHEMBL5699	Homo sapiens	Inhibition	%	11.62
	8182412	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.76	CHEMBL5699	Homo sapiens	Inhibition	%	3.76
	8182728	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	12.17	CHEMBL5699	Homo sapiens	Inhibition	%	12.17
	8183074	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	13.66	CHEMBL5699	Homo sapiens	Inhibition	%	13.66
	8183223	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	8.33	CHEMBL5699	Homo sapiens	Inhibition	%	8.33
	8183576	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	-0.15	CHEMBL5699	Homo sapiens	Inhibition	%	-0.15
	8183718	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	17.07	CHEMBL5699	Homo sapiens	Inhibition	%	17.07
	8183942	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.51	CHEMBL5699	Homo sapiens	Inhibition	%	3.51
	8184078	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	7.64	CHEMBL5699	Homo sapiens	Inhibition	%	7.64
	8184344	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	8.16	CHEMBL5699	Homo sapiens	Inhibition	%	8.16
	8184715	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	7.67	CHEMBL5699	Homo sapiens	Inhibition	%	7.67
	8184872	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	18.77	CHEMBL5699	Homo sapiens	Inhibition	%	18.77
	8185245	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-1.4	CHEMBL5699	Homo sapiens	Inhibition	%	-1.4
	8185376	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	52.61	CHEMBL5699	Homo sapiens	Inhibition	%	52.61
	8185600	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	5.71	CHEMBL5699	Homo sapiens	Inhibition	%	5.71
	8185731	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-0.55	CHEMBL5699	Homo sapiens	Inhibition	%	-0.55
	8186094	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	12.8	CHEMBL5699	Homo sapiens	Inhibition	%	12.8
	8186235	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	8.32	CHEMBL5699	Homo sapiens	Inhibition	%	8.32
	8186459	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	7.08	CHEMBL5699	Homo sapiens	Inhibition	%	7.08
	8186623	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	6.36	CHEMBL5699	Homo sapiens	Inhibition	%	6.36
	8186762	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.08	CHEMBL5699	Homo sapiens	Inhibition	%	2.08
	8186986	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	8.68	CHEMBL5699	Homo sapiens	Inhibition	%	8.68
	8187084	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	6.79	CHEMBL5699	Homo sapiens	Inhibition	%	6.79
	8187432	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	9.16	CHEMBL5699	Homo sapiens	Inhibition	%	9.16
	8187580	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	31.24	CHEMBL5699	Homo sapiens	Inhibition	%	31.24
	8187804	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.69	CHEMBL5699	Homo sapiens	Inhibition	%	1.69
	8187933	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	0.08	CHEMBL5699	Homo sapiens	Inhibition	%	0.08
	8188300	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	10.61	CHEMBL5699	Homo sapiens	Inhibition	%	10.61
	8188435	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	19.09	CHEMBL5699	Homo sapiens	Inhibition	%	19.09
	8188659	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	29.94	CHEMBL5699	Homo sapiens	Inhibition	%	29.94
	8188709	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.89	CHEMBL5699	Homo sapiens	Inhibition	%	4.89
	8188933	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	9.4	CHEMBL5699	Homo sapiens	Inhibition	%	9.4
	8189081	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	2.78	CHEMBL5699	Homo sapiens	Inhibition	%	2.78
	8189237	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	44.63	CHEMBL5699	Homo sapiens	Inhibition	%	44.63
	8189461	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	-0.72	CHEMBL5699	Homo sapiens	Inhibition	%	-0.72
	8189610	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	5.8	CHEMBL5699	Homo sapiens	Inhibition	%	5.8
	8189966	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	27.51	CHEMBL5699	Homo sapiens	Inhibition	%	27.51
	8190098	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	0.5	CHEMBL5699	Homo sapiens	Inhibition	%	0.5
	8190322	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	10.45	CHEMBL5699	Homo sapiens	Inhibition	%	10.45
	8190462	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	7.44	CHEMBL5699	Homo sapiens	Inhibition	%	7.44
	8190823	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.44	CHEMBL5699	Homo sapiens	Inhibition	%	4.44
	8190987	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	11.33	CHEMBL5699	Homo sapiens	Inhibition	%	11.33
	8191349	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	13.58	CHEMBL5699	Homo sapiens	Inhibition	%	13.58
	8191445	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	37.53	CHEMBL5699	Homo sapiens	Inhibition	%	37.53
	8191669	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.09	CHEMBL5699	Homo sapiens	Inhibition	%	2.09
	8191791	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	12.08	CHEMBL5699	Homo sapiens	Inhibition	%	12.08
	8192164	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	-1.33	CHEMBL5699	Homo sapiens	Inhibition	%	-1.33
	8192293	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	6.86	CHEMBL5699	Homo sapiens	Inhibition	%	6.86
	8192517	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	6.77	CHEMBL5699	Homo sapiens	Inhibition	%	6.77
	8192661	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	9.0	CHEMBL5699	Homo sapiens	Inhibition	%	9.0
	8193021	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.16	CHEMBL5699	Homo sapiens	Inhibition	%	-0.16
	8193293	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	7.37	CHEMBL5699	Homo sapiens	Inhibition	%	7.37
	8193438	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	23.1	CHEMBL5699	Homo sapiens	Inhibition	%	23.1
	8193819	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	11.35	CHEMBL5699	Homo sapiens	Inhibition	%	11.35
	8193968	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-7.08	CHEMBL5699	Homo sapiens	Inhibition	%	-7.08
	8194323	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	7.06	CHEMBL5699	Homo sapiens	Inhibition	%	7.06
	8194678	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.33	CHEMBL5699	Homo sapiens	Inhibition	%	1.33
	8194821	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	14.21	CHEMBL5699	Homo sapiens	Inhibition	%	14.21
	8195178	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	16.62	CHEMBL5699	Homo sapiens	Inhibition	%	16.62
	8195342	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	10.54	CHEMBL5699	Homo sapiens	Inhibition	%	10.54
	8195705	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	8.76	CHEMBL5699	Homo sapiens	Inhibition	%	8.76
	8196027	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	4.41	CHEMBL5699	Homo sapiens	Inhibition	%	4.41
	8196144	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.47	CHEMBL5699	Homo sapiens	Inhibition	%	2.47
	8196368	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	7.91	CHEMBL5699	Homo sapiens	Inhibition	%	7.91
	8196518	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	13.31	CHEMBL5699	Homo sapiens	Inhibition	%	13.31
	8196870	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	6.37	CHEMBL5699	Homo sapiens	Inhibition	%	6.37
	8197011	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	18.47	CHEMBL5699	Homo sapiens	Inhibition	%	18.47
	8197372	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.02	CHEMBL5699	Homo sapiens	Inhibition	%	2.02
	8197647	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	8.31	CHEMBL5699	Homo sapiens	Inhibition	%	8.31
	8197787	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.69	CHEMBL5699	Homo sapiens	Inhibition	%	2.69
	8198011	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	26.55	CHEMBL5699	Homo sapiens	Inhibition	%	26.55
	8198168	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.21	CHEMBL5699	Homo sapiens	Inhibition	%	1.21
	8198306	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-6.02	CHEMBL5699	Homo sapiens	Inhibition	%	-6.02
	8198530	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	7.67	CHEMBL5699	Homo sapiens	Inhibition	%	7.67
	8198660	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	18.93	CHEMBL5699	Homo sapiens	Inhibition	%	18.93
	8199015	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	5.15	CHEMBL5699	Homo sapiens	Inhibition	%	5.15
	8199163	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	8.08	CHEMBL5699	Homo sapiens	Inhibition	%	8.08
	8199387	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	7.99	CHEMBL5699	Homo sapiens	Inhibition	%	7.99
	8199521	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	9.03	CHEMBL5699	Homo sapiens	Inhibition	%	9.03
	8199684	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	6.6	CHEMBL5699	Homo sapiens	Inhibition	%	6.6
	8199908	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	10.51	CHEMBL5699	Homo sapiens	Inhibition	%	10.51
	8200046	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	7.48	CHEMBL5699	Homo sapiens	Inhibition	%	7.48
	8200374	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-1.6	CHEMBL5699	Homo sapiens	Inhibition	%	-1.6
	8200713	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	8.34	CHEMBL5699	Homo sapiens	Inhibition	%	8.34
	8200863	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	33.25	CHEMBL5699	Homo sapiens	Inhibition	%	33.25
	8201217	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	24.93	CHEMBL5699	Homo sapiens	Inhibition	%	24.93
	8201352	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	6.46	CHEMBL5699	Homo sapiens	Inhibition	%	6.46
	8201576	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	4.1	CHEMBL5699	Homo sapiens	Inhibition	%	4.1
	8201709	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-6.12	CHEMBL5699	Homo sapiens	Inhibition	%	-6.12
	8201988	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.19	CHEMBL5699	Homo sapiens	Inhibition	%	2.19
	8202352	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1	Outside typical range	CHEMBL1794053	=	Inhibition	%	-11.82	CHEMBL5699	Homo sapiens	Inhibition	%	-11.82
	8202519	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	7.35	CHEMBL5699	Homo sapiens	Inhibition	%	7.35
	8202868	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	8.0	CHEMBL5699	Homo sapiens	Inhibition	%	8.0
	8202998	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	8.29	CHEMBL5699	Homo sapiens	Inhibition	%	8.29
	8203222	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	13.61	CHEMBL5699	Homo sapiens	Inhibition	%	13.61
	8203353	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	3.64	CHEMBL5699	Homo sapiens	Inhibition	%	3.64
	8203723	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.35	CHEMBL5699	Homo sapiens	Inhibition	%	3.35
	8203857	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	6.72	CHEMBL5699	Homo sapiens	Inhibition	%	6.72
	8204247	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	12.35	CHEMBL5699	Homo sapiens	Inhibition	%	12.35
	8204384	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	6.77	CHEMBL5699	Homo sapiens	Inhibition	%	6.77
	8204608	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	23.93	CHEMBL5699	Homo sapiens	Inhibition	%	23.93
	8204713	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	13.9	CHEMBL5699	Homo sapiens	Inhibition	%	13.9
	8205052	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	33.12	CHEMBL5699	Homo sapiens	Inhibition	%	33.12
	8205201	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	6.34	CHEMBL5699	Homo sapiens	Inhibition	%	6.34
	8205425	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	7.7	CHEMBL5699	Homo sapiens	Inhibition	%	7.7
	8205561	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	4.45	CHEMBL5699	Homo sapiens	Inhibition	%	4.45
	8205924	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	5.46	CHEMBL5699	Homo sapiens	Inhibition	%	5.46
	8206056	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.83	CHEMBL5699	Homo sapiens	Inhibition	%	-0.83
	8206332	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	10.8	CHEMBL5699	Homo sapiens	Inhibition	%	10.8
	8206699	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.64	CHEMBL5699	Homo sapiens	Inhibition	%	-0.64
	8206879	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	-0.97	CHEMBL5699	Homo sapiens	Inhibition	%	-0.97
	8207229	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.96	CHEMBL5699	Homo sapiens	Inhibition	%	4.96
	8207583	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	14.23	CHEMBL5699	Homo sapiens	Inhibition	%	14.23
	8207715	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	9.51	CHEMBL5699	Homo sapiens	Inhibition	%	9.51
	8208084	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.87	CHEMBL5699	Homo sapiens	Inhibition	%	2.87
	8208216	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.82	CHEMBL5699	Homo sapiens	Inhibition	%	3.82
	8208440	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	11.27	CHEMBL5699	Homo sapiens	Inhibition	%	11.27
	8208606	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	5.77	CHEMBL5699	Homo sapiens	Inhibition	%	5.77
	8208963	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.75	CHEMBL5699	Homo sapiens	Inhibition	%	0.75
	8209068	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-1.84	CHEMBL5699	Homo sapiens	Inhibition	%	-1.84
	8209292	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	6.03	CHEMBL5699	Homo sapiens	Inhibition	%	6.03
	8209408	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	4.07	CHEMBL5699	Homo sapiens	Inhibition	%	4.07
	8209782	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.79	CHEMBL5699	Homo sapiens	Inhibition	%	1.79
	8209918	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	9.31	CHEMBL5699	Homo sapiens	Inhibition	%	9.31
	8210283	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.87	CHEMBL5699	Homo sapiens	Inhibition	%	4.87
	8210419	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O	Outside typical range	CHEMBL2062290	=	Inhibition	%	-10.35	CHEMBL5699	Homo sapiens	Inhibition	%	-10.35
	8210643	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-4.25	CHEMBL5699	Homo sapiens	Inhibition	%	-4.25
	8210678	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	5.11	CHEMBL5699	Homo sapiens	Inhibition	%	5.11
	8210902	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	11.42	CHEMBL5699	Homo sapiens	Inhibition	%	11.42
	8211046	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	5.85	CHEMBL5699	Homo sapiens	Inhibition	%	5.85
	8211216	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	5.74	CHEMBL5699	Homo sapiens	Inhibition	%	5.74
	8211440	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.92	CHEMBL5699	Homo sapiens	Inhibition	%	2.92
	8211563	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	14.58	CHEMBL5699	Homo sapiens	Inhibition	%	14.58
	8211916	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	19.91	CHEMBL5699	Homo sapiens	Inhibition	%	19.91
	8212048	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	1.16	CHEMBL5699	Homo sapiens	Inhibition	%	1.16
	8212272	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.39	CHEMBL5699	Homo sapiens	Inhibition	%	3.39
	8212413	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	5.76	CHEMBL5699	Homo sapiens	Inhibition	%	5.76
	8212770	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	12.93	CHEMBL5699	Homo sapiens	Inhibition	%	12.93
	8212940	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	4.09	CHEMBL5699	Homo sapiens	Inhibition	%	4.09
	8213293	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.93	CHEMBL5699	Homo sapiens	Inhibition	%	5.93
	8213621	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-6.0	CHEMBL5699	Homo sapiens	Inhibition	%	-6.0
	8213734	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	4.74	CHEMBL5699	Homo sapiens	Inhibition	%	4.74
	8214105	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	8.87	CHEMBL5699	Homo sapiens	Inhibition	%	8.87
	8214242	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	10.86	CHEMBL5699	Homo sapiens	Inhibition	%	10.86
	8214466	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	24.77	CHEMBL5699	Homo sapiens	Inhibition	%	24.77
	8214600	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	13.11	CHEMBL5699	Homo sapiens	Inhibition	%	13.11
	8214976	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-6.26	CHEMBL5699	Homo sapiens	Inhibition	%	-6.26
	8215227	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	7.84	CHEMBL5699	Homo sapiens	Inhibition	%	7.84
	8215380	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	15.24	CHEMBL5699	Homo sapiens	Inhibition	%	15.24
	8215768	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	7.13	CHEMBL5699	Homo sapiens	Inhibition	%	7.13
	8215887	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	4.52	CHEMBL5699	Homo sapiens	Inhibition	%	4.52
	8216111	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	9.21	CHEMBL5699	Homo sapiens	Inhibition	%	9.21
	8216230	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	5.75	CHEMBL5699	Homo sapiens	Inhibition	%	5.75
	8216590	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	5.12	CHEMBL5699	Homo sapiens	Inhibition	%	5.12
	8216728	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	7.9	CHEMBL5699	Homo sapiens	Inhibition	%	7.9
	8216952	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.71	CHEMBL5699	Homo sapiens	Inhibition	%	5.71
	8217086	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	5.76	CHEMBL5699	Homo sapiens	Inhibition	%	5.76
	8217260	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.87	CHEMBL5699	Homo sapiens	Inhibition	%	1.87
	8217484	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.2	CHEMBL5699	Homo sapiens	Inhibition	%	1.2
	8217615	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	21.95	CHEMBL5699	Homo sapiens	Inhibition	%	21.95
	8217940	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-3.21	CHEMBL5699	Homo sapiens	Inhibition	%	-3.21
	8218055	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	6.15	CHEMBL5699	Homo sapiens	Inhibition	%	6.15
	8218279	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.63	CHEMBL5699	Homo sapiens	Inhibition	%	2.63
	8218406	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	34.56	CHEMBL5699	Homo sapiens	Inhibition	%	34.56
	8218773	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	11.88	CHEMBL5699	Homo sapiens	Inhibition	%	11.88
	8218904	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	53.5	CHEMBL5699	Homo sapiens	Inhibition	%	53.5
	8219128	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	6.29	CHEMBL5699	Homo sapiens	Inhibition	%	6.29
	8219288	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-0.03	CHEMBL5699	Homo sapiens	Inhibition	%	-0.03
	8219538	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	11.57	CHEMBL5699	Homo sapiens	Inhibition	%	11.57
	8219699	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	5.46	CHEMBL5699	Homo sapiens	Inhibition	%	5.46
	8219923	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	7.65	CHEMBL5699	Homo sapiens	Inhibition	%	7.65
	8220092	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	9.9	CHEMBL5699	Homo sapiens	Inhibition	%	9.9
	8220445	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.95	CHEMBL5699	Homo sapiens	Inhibition	%	2.95
	8220559	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	9.85	CHEMBL5699	Homo sapiens	Inhibition	%	9.85
	8220783	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	4.56	CHEMBL5699	Homo sapiens	Inhibition	%	4.56
	8220921	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	21.02	CHEMBL5699	Homo sapiens	Inhibition	%	21.02
	8221281	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.36	CHEMBL5699	Homo sapiens	Inhibition	%	2.36
	8221414	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	5.27	CHEMBL5699	Homo sapiens	Inhibition	%	5.27
	8221803	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	8.02	CHEMBL5699	Homo sapiens	Inhibition	%	8.02
	8221934	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	69.43	CHEMBL5699	Homo sapiens	Inhibition	%	69.43
	8222256	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.14	CHEMBL5699	Homo sapiens	Inhibition	%	3.14
	8222614	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	6.43	CHEMBL5699	Homo sapiens	Inhibition	%	6.43
	8222732	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	75.95	CHEMBL5699	Homo sapiens	Inhibition	%	75.95
	8222956	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	4.07	CHEMBL5699	Homo sapiens	Inhibition	%	4.07
	8223100	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	10.68	CHEMBL5699	Homo sapiens	Inhibition	%	10.68
	8223453	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	6.45	CHEMBL5699	Homo sapiens	Inhibition	%	6.45
	8223614	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-5.52	CHEMBL5699	Homo sapiens	Inhibition	%	-5.52
	8223864	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.7	CHEMBL5699	Homo sapiens	Inhibition	%	3.7
	8224250	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	0.28	CHEMBL5699	Homo sapiens	Inhibition	%	0.28
	8224420	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	12.51	CHEMBL5699	Homo sapiens	Inhibition	%	12.51
	8224779	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	9.59	CHEMBL5699	Homo sapiens	Inhibition	%	9.59
	8225117	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	11.76	CHEMBL5699	Homo sapiens	Inhibition	%	11.76
	8225251	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.19	CHEMBL5699	Homo sapiens	Inhibition	%	6.19
	8225613	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.11	CHEMBL5699	Homo sapiens	Inhibition	%	0.11
	8225748	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.22	CHEMBL5699	Homo sapiens	Inhibition	%	4.22
	8225972	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	5.2	CHEMBL5699	Homo sapiens	Inhibition	%	5.2
	8226130	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	47.13	CHEMBL5699	Homo sapiens	Inhibition	%	47.13
	8226255	CHEMBL1962002	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	5.11	CHEMBL5699	Homo sapiens	Inhibition	%	5.11
	8226479	CHEMBL1962003	GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	8.28	CHEMBL5699	Homo sapiens	Inhibition	%	8.28
active	9595913	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	NC(=O)c1ccc(NC2CCCCC2N)nc1Nc1cccc(Cl)c1		CHEMBL1982753	=	Ki	nM	251.19	CHEMBL5699	Homo sapiens	pKi		6.6
inactive	9595914	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	3981.07	CHEMBL5699	Homo sapiens	pKi		5.4
active	9595915	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	Oc1cc(O)cc(C=Cc2ccc(O)c(O)c2)c1		CHEMBL1972346	=	Ki	nM	100.0	CHEMBL5699	Homo sapiens	pKi		7.0
inactive	9595916	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	3981.07	CHEMBL5699	Homo sapiens	pKi		5.4
active	9595917	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Ki	nM	0.7943	CHEMBL5699	Homo sapiens	pKi		9.1
active	9595918	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	630.96	CHEMBL5699	Homo sapiens	pKi		6.2
inactive	9595919	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	3981.07	CHEMBL5699	Homo sapiens	pKi		5.4
active	9595920	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	199.53	CHEMBL5699	Homo sapiens	pKi		6.7
active	9595921	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	15.85	CHEMBL5699	Homo sapiens	pKi		7.8
inactive	9595922	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	3981.07	CHEMBL5699	Homo sapiens	pKi		5.4
inactive	9595923	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	3981.07	CHEMBL5699	Homo sapiens	pKi		5.4
active	9595924	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	251.19	CHEMBL5699	Homo sapiens	pKi		6.6
active	9595925	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	316.23	CHEMBL5699	Homo sapiens	pKi		6.5
inactive	9595926	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	3981.07	CHEMBL5699	Homo sapiens	pKi		5.4
inactive	9595927	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	<	Ki	nM	3981.07	CHEMBL5699	Homo sapiens	pKi		5.4
inactive	9595928	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	3981.07	CHEMBL5699	Homo sapiens	pKi		5.4
active	9595929	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Ki	nM	251.19	CHEMBL5699	Homo sapiens	pKi		6.6
active	9595930	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	316.23	CHEMBL5699	Homo sapiens	pKi		6.5
inactive	9595931	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	Ki	nM	3981.07	CHEMBL5699	Homo sapiens	pKi		5.4
inactive	9595932	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	<	Ki	nM	3981.07	CHEMBL5699	Homo sapiens	pKi		5.4
inactive	9595933	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	3981.07	CHEMBL5699	Homo sapiens	pKi		5.4
active	9595934	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	1000.0	CHEMBL5699	Homo sapiens	pKi		6.0
inactive	9595935	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	3981.07	CHEMBL5699	Homo sapiens	pKi		5.4
active	9595936	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	=	Ki	nM	1258.93	CHEMBL5699	Homo sapiens	pKi		5.9
inactive	9595937	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	3981.07	CHEMBL5699	Homo sapiens	pKi		5.4
inactive	9595938	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	<	Ki	nM	3981.07	CHEMBL5699	Homo sapiens	pKi		5.4
active	9595939	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	316.23	CHEMBL5699	Homo sapiens	pKi		6.5
active	9595940	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	25.12	CHEMBL5699	Homo sapiens	pKi		7.6
active	9595941	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	398.11	CHEMBL5699	Homo sapiens	pKi		6.4
active	9595942	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Ki	nM	1000.0	CHEMBL5699	Homo sapiens	pKi		6.0
active	9595943	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	100.0	CHEMBL5699	Homo sapiens	pKi		7.0
active	9595944	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Ki	nM	25.12	CHEMBL5699	Homo sapiens	pKi		7.6
inactive	9595945	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	3981.07	CHEMBL5699	Homo sapiens	pKi		5.4
active	9595946	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	0.631	CHEMBL5699	Homo sapiens	pKi		9.2
inactive	9595947	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	3981.07	CHEMBL5699	Homo sapiens	pKi		5.4
active	9595948	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	1.0	CHEMBL5699	Homo sapiens	pKi		9.0
inactive	9595949	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	3981.07	CHEMBL5699	Homo sapiens	pKi		5.4
active	9595950	CHEMBL1963784	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SIK2	F	c1ccc(-c2c[nH]c3ncnc(N4CCCCC4)c23)cc1		CHEMBL1998953	=	Ki	nM	501.19	CHEMBL5699	Homo sapiens	pKi		6.3
	10839474	CHEMBL2015505	Inhibition of QIK at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	26.0	CHEMBL5699	Homo sapiens	INH	%	26.0
	12047349	CHEMBL2157702	Inhibition of SIK2 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-0.6	CHEMBL5699	Homo sapiens	INH	%	-0.6
	12170735	CHEMBL2214643	Inhibition of SIK2 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	108.0	CHEMBL5699	Homo sapiens	Activity	%	108.0
	12170866	CHEMBL2213185	Inhibition of SIK2 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	111.0	CHEMBL5699	Homo sapiens	Activity	%	111.0
	12172205	CHEMBL2209696	Inhibition of SIK2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	26.0	CHEMBL5699	Homo sapiens	Activity	%	26.0
	12183814	CHEMBL2214447	Inhibition of SIK2	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL5699	Homo sapiens	pIC50		5.0
	12727612	CHEMBL2352803	Inhibition of SIK2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	87.0	CHEMBL5699	Homo sapiens	Activity	%	87.0
	12728935	CHEMBL2352834	Inhibition of SNF1LK2 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	100.0	CHEMBL5699	Homo sapiens	Activity	%	100.0
	12729822	CHEMBL2352155	Inhibition of SIK2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	103.0	CHEMBL5699	Homo sapiens	Activity	%	103.0
	12730078	CHEMBL2351113	Inhibition of SNF1LK2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	91.0	CHEMBL5699	Homo sapiens	Activity	%	91.0
	13374346	CHEMBL2405675	Inhibition of SNF1LK2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	1.0	CHEMBL5699	Homo sapiens	INH	%	1.0
	13439749	CHEMBL2428990	Competitive binding affinity to SNF1LK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL5699	Homo sapiens	INH	%	50.0
	13442592	CHEMBL2427776	Competitive binding affinity to QIK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL5699	Homo sapiens	INH	%	50.0
	13445582	CHEMBL2428990	Competitive binding affinity to SNF1LK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL5699	Homo sapiens	INH	%	50.0
	13451569	CHEMBL2428990	Competitive binding affinity to SNF1LK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	73.0	CHEMBL5699	Homo sapiens	INH	%	73.0
	15056472	CHEMBL3363360	Inhibition of QIK (unknown origin) by Off-chip Mobility Shift Assay	B	CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL3326006	=	IC50	nM	5.75	CHEMBL5699	Homo sapiens	IC50	nM	5.75
	15058853	CHEMBL3371407	Inhibition of SNF1LK2 (unknown origin) assessed as residual activity at 1 uM by radiometric protein kinase assay	B	COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O		CHEMBL3358999	=	Activity	%	43.0	CHEMBL5699	Homo sapiens	Activity	%	43.0
	15072438	CHEMBL3388055	Inhibition of SIK2 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	106.0	CHEMBL5699	Homo sapiens	Activity	%	106.0
	15756815	CHEMBL3631471	Inhibition of SIK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	19.23	CHEMBL5699	Homo sapiens	INH	%	19.23
	15757908	CHEMBL3631471	Inhibition of SIK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	97.15	CHEMBL5699	Homo sapiens	INH	%	97.15
	15758887	CHEMBL3631471	Inhibition of SIK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	16.99	CHEMBL5699	Homo sapiens	INH	%	16.99
	16425250	CHEMBL3751273	Inhibition of SIK2 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-3.9	CHEMBL5699	Homo sapiens	INH	%	-3.9
	16432003	CHEMBL3750157	Inhibition of human SIK2 using [AMARAASAAALARRR] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL5699	Homo sapiens	IC50	uM	10.0
	16451610	CHEMBL3761191	Inhibition of SIK2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	35.3	CHEMBL5699	Homo sapiens	INH	%	35.3
	16483322	CHEMBL3772533	Inhibition of human SIK2	B	CNc1ncc2cc(-c3ccc(-c4cccc(C)n4)cc3Cl)c(=O)n(C[C@H]3OC[C@H](N)CO3)c2n1		CHEMBL3770443	=	IC50	nM	9.0	CHEMBL5699	Homo sapiens	IC50	nM	9.0
	16483334	CHEMBL3772907	Inhibition of human recombinant SIK2 at 0.1 uM	B	CNc1ncc2cc(-c3ccc(-c4cccc(C)n4)cc3Cl)c(=O)n(C[C@H]3OC[C@H](N)CO3)c2n1		CHEMBL3770443	>	Inhibition	%	70.0	CHEMBL5699	Homo sapiens	INH	%	70.0
	16515252	CHEMBL3784254	Inhibition of SNF1LK2 (unknown origin)	B	N[C@H]1CC[C@@H](Nc2cc[nH]c(=O)c2-c2nc3ccccc3[nH]2)CC1		CHEMBL3780091	=	IC50	nM	4.0	CHEMBL5699	Homo sapiens	IC50	nM	4.0
Active	16565778	CHEMBL3801311	Inhibition of human SIK2 at 300 nM using AMARAASAAALARRR as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C(=O)Oc1cccc(NC(=O)C2(CN)CCN(c3ncnc4[nH]c5c(c34)CCCC5)CC2)c1		CHEMBL3797874		Inhibition	%		CHEMBL5699	Homo sapiens	INH		
	16614629	CHEMBL3816845	Inhibition of human SIK2 at 1 uM using [AMARAASAAALARRR] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	36.0	CHEMBL5699	Homo sapiens	INH	%	36.0
	16618655	CHEMBL3816614	Inhibition of SIK2 (unknown origin) at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL5699	Homo sapiens	INH	%	50.0
	16619640	CHEMBL3820370	Inhibition of recombinant human full length GST-tagged SIK2 expressed in Baculovirus at 1 uM relative to control	B	CNc1ncc2cc(-c3ccc(-n4cncc(C)c4=O)cc3Cl)c(=O)n(CCOC)c2n1		CHEMBL3819447	>	Inhibition	%	75.0	CHEMBL5699	Homo sapiens	INH	%	75.0
	16619703	CHEMBL3820370	Inhibition of recombinant human full length GST-tagged SIK2 expressed in Baculovirus at 1 uM relative to control	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Inhibition	%	75.0	CHEMBL5699	Homo sapiens	INH	%	75.0
	16654132	CHEMBL3829190	Inhibition of human SIK2 (2 to 962 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	19.0	CHEMBL5699	Homo sapiens	Activity	%	19.0
	16804196	CHEMBL3869711	Inhibition of human recombinant full length GST-tagged SNF1LK2 expressed in baculovirus expression system at 200 nM by Z'-LYTE assay	B	Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1		CHEMBL3979920	=	Inhibition	%	72.0	CHEMBL5699	Homo sapiens	INH	%	72.0
Inactive	17937906	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937907	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937908	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17937909	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1149.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	1149.0
Inactive	17937910	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937911	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937912	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937913	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937914	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937915	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937916	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937917	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17937918	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	206.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	206.0
Inactive	17937919	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937920	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937921	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937922	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937923	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937924	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937925	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937926	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937927	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937928	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937929	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17937930	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	110.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	110.0
Inactive	17937931	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937932	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937933	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937934	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937935	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937936	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937937	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937938	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17937939	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	115.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	115.0
Inactive	17937940	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17937941	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	47.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	47.0
Active	17937942	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	=	Kd	nM	16.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	16.0
Active	17937943	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	58.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	58.0
Inactive	17937944	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17937945	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	=	Kd	nM	123.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	123.0
Inactive	17937946	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937947	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937948	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937949	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937950	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937951	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937952	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937953	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937954	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937955	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937956	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937957	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17937958	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	=	Kd	nM	207.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	207.0
Inactive	17937959	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937960	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937961	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937962	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937963	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937964	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937965	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937966	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937967	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937968	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17937969	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	1267.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	1267.0
Inactive	17937970	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937971	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937972	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937973	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937974	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17937975	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	7.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	7.0
Inactive	17937976	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937977	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937978	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937979	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937980	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937981	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937982	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937983	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17937984	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	685.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	685.0
Active	17937985	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	1255.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	1255.0
Inactive	17937986	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937987	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937988	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937989	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17937990	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	30.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30.0
Inactive	17937991	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937992	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937993	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937994	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937995	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937996	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937997	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17937998	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	=	Kd	nM	270.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	270.0
Inactive	17937999	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938000	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938001	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938002	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938003	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938004	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938005	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938006	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938007	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938008	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938009	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17938010	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	11.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	11.0
Inactive	17938011	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938012	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938013	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938014	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938015	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938016	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938017	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938018	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938019	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938020	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938021	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938022	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938023	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17938024	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	890.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	890.0
Inactive	17938025	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938026	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938027	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938028	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17938029	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	Kd	nM	2.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	2.0
Inactive	17938030	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938031	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938032	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17938033	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	48.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	48.0
Inactive	17938034	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938035	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17938036	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	=	Kd	nM	2492.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	2492.0
Inactive	17938037	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938038	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938039	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17938040	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Kd	nM	904.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	904.0
Inactive	17938041	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938042	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17938043	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	11.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	11.0
Inactive	17938044	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938045	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938046	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938047	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938048	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938049	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938050	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938051	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938052	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938053	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938054	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938055	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938056	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938057	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17938058	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	=	Kd	nM	6124.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	6124.0
Inactive	17938059	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938060	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938061	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938062	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17938063	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	55.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	55.0
Inactive	17938064	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938065	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938066	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938067	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938068	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938069	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938070	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938071	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938072	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938073	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938074	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938075	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938076	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17938077	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	25.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	25.0
Active	17938078	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	3513.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	3513.0
Inactive	17938079	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938080	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17938081	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	=	Kd	nM	41795.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	41795.0
Active	17938082	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	649.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	649.0
Inactive	17938083	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938084	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938085	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938086	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938087	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17938088	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	122.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	122.0
Inactive	17938089	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938090	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17938091	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	1796.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	1796.0
Inactive	17938092	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938093	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17938094	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	=	Kd	nM	790.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	790.0
Inactive	17938095	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938096	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938097	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938098	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17938099	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	1008.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	1008.0
Inactive	17938100	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938101	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938102	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938103	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938104	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938105	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938106	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938107	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938108	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938109	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938110	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938111	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938112	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17938113	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	1407.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	1407.0
Inactive	17938114	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938115	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938116	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938117	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938118	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938119	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938120	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938121	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938122	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938123	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938124	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938125	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938126	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17938127	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	1405.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	1405.0
Inactive	17938128	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938129	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938130	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938131	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938132	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938133	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938134	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938135	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938136	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17938137	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	1296.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	1296.0
Inactive	17938138	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938139	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938140	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938141	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938142	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17938143	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	=	Kd	nM	300.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	300.0
Inactive	17938144	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Active	17938145	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	=	Kd	nM	128.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	128.0
Active	17938146	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	240.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	240.0
Inactive	17938147	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17938148	CHEMBL3991879	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL5699	Homo sapiens	Kd apparent	nM	30000.0
	18048731	CHEMBL4011077	Inhibition of SIK2 (unknown origin) at 0.5 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Inhibition	%	46.0	CHEMBL5699	Homo sapiens	INH	%	46.0
	18052929	CHEMBL4011941	Inhibition of QIK (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	1.0	CHEMBL5699	Homo sapiens	INH	%	1.0
	18114857	CHEMBL4025387	Inhibition of wild-type human full length SIK2 (M1 to N926 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	87.0	CHEMBL5699	Homo sapiens	Activity	%	87.0
	18203911	CHEMBL4044198	Inhibition of wild-type human full length SIK2 (M1 to N926 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	89.0	CHEMBL5699	Homo sapiens	Activity	%	89.0
	18211555	CHEMBL4045758	Inhibition of QIK conserved Lys1 (EVAIKIIDK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-23.4	CHEMBL5699	Homo sapiens	INH	%	-23.4
	18211903	CHEMBL4045999	Inhibition of QIK conserved Lys1 (EVAIKIIDK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-6.7	CHEMBL5699	Homo sapiens	INH	%	-6.7
	18232102	CHEMBL4050400	Inhibition of human SIK2 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	99.0	CHEMBL5699	Homo sapiens	Activity	%	99.0
	18253269	CHEMBL4054918	Inhibition of wild-type human full length QIK (M1 to N926 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	36.0	CHEMBL5699	Homo sapiens	Activity	%	36.0
	18253270	CHEMBL4054918	Inhibition of wild-type human full length QIK (M1 to N926 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	63.0	CHEMBL5699	Homo sapiens	Activity	%	63.0
	18282195	CHEMBL4120150	Inhibition of SIK2 (unknown origin) at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	10.8	CHEMBL5699	Homo sapiens	INH	%	10.8
	18282514	CHEMBL4120150	Inhibition of SIK2 (unknown origin) at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	18.4	CHEMBL5699	Homo sapiens	INH	%	18.4
	18440453	CHEMBL4157277	Binding affinity to wild-type human full length SIK2 (M1 to N926 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	90.0	CHEMBL5699	Homo sapiens	Activity	%	90.0
	18449877	CHEMBL4178111	Inhibition of human SIK2 (2 to 926 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	105.0	CHEMBL5699	Homo sapiens	Activity	%	105.0
	18477349	CHEMBL4183785	Inhibition of full length human N-terminal GST-tagged QIK expressed in baculovirus expression system at 10 nM relative to control	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373	>	Inhibition	%	90.0	CHEMBL5699	Homo sapiens	INH	%	90.0
	18484409	CHEMBL4186056	Binding affinity to wild-type human full length SIK2 (M1 to N926 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	89.0	CHEMBL5699	Homo sapiens	Activity	%	89.0
	18484893	CHEMBL4186056	Binding affinity to wild-type human full length SIK2 (M1 to N926 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	78.0	CHEMBL5699	Homo sapiens	Activity	%	78.0
	18507603	CHEMBL4191195	Inhibition of recombinant human SIK2 (1 to 276 residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	21.0	CHEMBL5699	Homo sapiens	INH	%	21.0
	18653361	CHEMBL4230225	Inhibition of SNF1LK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	7.0	CHEMBL5699	Homo sapiens	INH	%	7.0
	18653362	CHEMBL4230225	Inhibition of SNF1LK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	10.0	CHEMBL5699	Homo sapiens	INH	%	10.0
	18655279	CHEMBL4230956	Binding affinity to wild-type human full length SIK2 (M1 to N926 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	87.0	CHEMBL5699	Homo sapiens	Activity	%	87.0
	18751239	CHEMBL4263948	Inhibition of SNF1LK2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	37.0	CHEMBL5699	Homo sapiens	INH	%	37.0
	18752208	CHEMBL4264545	Binding affinity to wild-type human full length SIK2 (M1 to N926 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL5699	Homo sapiens	Activity	%	100.0
	18781597	CHEMBL4270226	Inhibition of human SIK2 using AMARAASAAALARRR as substrate in presence of [gamma33P]ATP by kinase hotspot assay	B	CCN1CCN(Cc2ccc(Nc3nccc(-c4cnc(N5CC[C@H](F)C5)c(C#N)c4)n3)cn2)CC1	Non standard unit for type	CHEMBL4295211	=	INH	nM	7.0	CHEMBL5699	Homo sapiens	INH	nM	7.0
	18812586	CHEMBL4276358	Inhibition of N-terminal GST-tagged full length human QIK (1 to 926 end residues) expressed in baculovirus expression system using fluorecence-labeled substrate by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4283353	>	IC50	nM	100.0	CHEMBL5699	Homo sapiens	IC50	nM	100.0
	18812739	CHEMBL4276358	Inhibition of N-terminal GST-tagged full length human QIK (1 to 926 end residues) expressed in baculovirus expression system using fluorecence-labeled substrate by MCE assay	B	CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL3326006	=	IC50	nM	5.75	CHEMBL5699	Homo sapiens	IC50	nM	5.75
	18858208	CHEMBL4308054	Binding affinity to wild-type human full length SIK2 (M1 to N926 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL5699	Homo sapiens	Activity	%	100.0
	18892719	CHEMBL4314530	Inhibition of human SIK2 (1 to 276 residues) using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	97.0	CHEMBL5699	Homo sapiens	Activity	%	97.0
	18919501	CHEMBL4322858	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged SIK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	4.0	CHEMBL5699	Homo sapiens	Kd	nM	4.0
	18919689	CHEMBL4322858	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged SIK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	3.0	CHEMBL5699	Homo sapiens	Kd	nM	3.0
	18938299	CHEMBL4327876	Inhibition of human SIK2 assessed as residual activity at 1 uM using AMARAASAAALARRR as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	108.67	CHEMBL5699	Homo sapiens	Activity	%	108.67
	18938300	CHEMBL4327876	Inhibition of human SIK2 assessed as residual activity at 1 uM using AMARAASAAALARRR as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	103.77	CHEMBL5699	Homo sapiens	Activity	%	103.77
	18938721	CHEMBL4328240	Inhibition of human SIK2 assessed as residual activity at 100 uM using AMARAASAAALARRR as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL5699	Homo sapiens	Activity	%	65.0
	18939107	CHEMBL4328604	Inhibition of human SIK2 using AMARAASAAALARRR as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.37	CHEMBL5699	Homo sapiens	IC50	10'-10M	3.7
	18958555	CHEMBL4333636	Binding affinity to wild-type human full length SIK2 (M1 to N926 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	92.0	CHEMBL5699	Homo sapiens	Activity	%	92.0
	18964694	CHEMBL4335288	Inhibition of recombinant human SIK2 (1 to 276 residues) assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	99.0	CHEMBL5699	Homo sapiens	Activity	%	99.0
	18964695	CHEMBL4335288	Inhibition of recombinant human SIK2 (1 to 276 residues) assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	104.0	CHEMBL5699	Homo sapiens	Activity	%	104.0
	18972103	CHEMBL4337113	Inhibition of recombinant human SIK2 (1 to 276 residues) assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	7.0	CHEMBL5699	Homo sapiens	Activity	%	7.0
Not Active	19040161	CHEMBL4352062	Inhibition of human SIK2 (1 to 276 residues) using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL5699	Homo sapiens	INH		
Active	19041281	CHEMBL4352542	Inhibition of human SIK2 at 10 uM using AMARAASAAALARRR as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5699	Homo sapiens	INH		
	19059833	CHEMBL4358134	Binding affinity to wild-type human full length SIK2 (M1 to N926 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	67.0	CHEMBL5699	Homo sapiens	Activity	%	67.0
	19090397	CHEMBL4365971	Inhibition of wild-type human full length SIK2 (M1 to N926 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL5699	Homo sapiens	Activity	%	100.0
	19092115	CHEMBL4366589	Inhibition of human SIK2 at 100 nM using AMARAASAAALARRR as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-3.42	CHEMBL5699	Homo sapiens	INH	%	-3.42
	19114475	CHEMBL4371444	Binding affinity to QIK in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Kd	nM	4518.0	CHEMBL5699	Homo sapiens	Kd(free)	uM	4.518
	19114714	CHEMBL4371444	Binding affinity to QIK in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Kd	nM	3545.0	CHEMBL5699	Homo sapiens	Kd(free)	uM	3.545
	19148041	CHEMBL4379437	Inhibition of recombinant human SIK2 (1 to 276 residues) using KKKVSRSGLYRSP as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL5699	Homo sapiens	IC50	uM	10.0
	19159661	CHEMBL4382765	Binding affinity to wild-type human full length SIK2 (M1 to N926 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	38.0	CHEMBL5699	Homo sapiens	Activity	%	38.0
	19181144	CHEMBL4387355	Inhibition of recombinant full length human GST-tagged SIK2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-25 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	6.0	CHEMBL5699	Homo sapiens	INH	%	6.0
	19181369	CHEMBL4387355	Inhibition of recombinant full length human GST-tagged SIK2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-25 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	26.5	CHEMBL5699	Homo sapiens	INH	%	26.5
	19191346	CHEMBL4389484	Inhibition of wild-type human full length SIK2 (M1 to N926 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	84.0	CHEMBL5699	Homo sapiens	INH	%	84.0
	19192147	CHEMBL4389961	Inhibition of wild-type human full length SIK2 (M1 to N926 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	93.0	CHEMBL5699	Homo sapiens	INH	%	93.0
	19200403	CHEMBL4391587	Binding affinity to wild-type human full length SIK2 (M1 to N926 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	36.0	CHEMBL5699	Homo sapiens	Activity	%	36.0
	19218928	CHEMBL4394543	Binding affinity to wild-type human full length SIK2 (M1 to N926 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	<	Kd	nM	225.0	CHEMBL5699	Homo sapiens	Kd	nM	225.0
	19266614	CHEMBL4405564	Inhibition of wild-type human full length SIK2 (M1 to N926 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5699	Homo sapiens	INH	%	50.0
	19276130	CHEMBL4408133	Inhibition of recombinant human SIK2 (1 to 276 residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	43.0	CHEMBL5699	Homo sapiens	INH	%	43.0
	19292304	CHEMBL4411555	Inhibition of N-terminal GST tagged full length human QIK (1 to 926 end residues) expressed in baculovirus expression system at 1 uM in presence of ATP at its Km level relative to control	B	Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1		CHEMBL4458435	=	Inhibition	%	91.0	CHEMBL5699	Homo sapiens	INH	%	91.0
	20600671	CHEMBL4603623	Inhibition of recombinant full length GST-tagged human SNF1LK2 expressed in baculovirus expression system using Ser/Thr 25 as substrate in presence of ATP after 1 hr by Z'LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL5699	Homo sapiens	IC50	uM	100.0
	20694105	CHEMBL4626198	Inhibition of SIK2 (unknown origin)	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4517408	=	IC50	nM	336.0	CHEMBL5699	Homo sapiens	IC50	nM	336.0
	20694143	CHEMBL4626223	Inhibition of SIK2 (unknown origin) at 1 uM relative to control	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1F		CHEMBL4636120	>	Inhibition	%	50.0	CHEMBL5699	Homo sapiens	INH	%	50.0
	22392165	CHEMBL4667260	Inhibition of SIK2 (unknown origin) by selectscreen kinase assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	3.0	CHEMBL5699	Homo sapiens	INH	%	3.0
	22423074	CHEMBL4674089	Inhibition of human SIK2 using AMARAASAAALARRR as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Inhibition	%	80.0	CHEMBL5699	Homo sapiens	INH	%	80.0
	22423243	CHEMBL4674197	Inhibition of human SIK2 using AMARAASAAALARRR as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	62.07	CHEMBL5699	Homo sapiens	Activity	%	62.07
	22423244	CHEMBL4674197	Inhibition of human SIK2 using AMARAASAAALARRR as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	23.57	CHEMBL5699	Homo sapiens	Activity	%	23.57
	22843569	CHEMBL4720555	Inhibition of human SIK2 using AMARAASAAALARRR as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.345	CHEMBL5699	Homo sapiens	IC50	10^-10M	3.45
	22843912	CHEMBL4720898	Inhibition of human SIK2 assessed as residual activity using AMARAASAAALARRR as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	77.79	CHEMBL5699	Homo sapiens	Activity	%	77.79
	22844864	CHEMBL4721539	Inhibition of wild-type human full length SIK2 (M1 to N926 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	97.05	CHEMBL5699	Homo sapiens	Activity	%	97.05
	22953000	CHEMBL4766937	Inhibition of recombinant human SIK2 (1 to 276 residues) assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	93.0	CHEMBL5699	Homo sapiens	Activity	%	93.0
	23122818	CHEMBL4805169	Inhibition of human SIK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	100.0	CHEMBL5699	Homo sapiens	Activity	%	100.0
	23123513	CHEMBL4805757	Inhibition of human SIK2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	81.0	CHEMBL5699	Homo sapiens	Activity	%	81.0
	23123965	CHEMBL4806209	Inhibition of DNA-tagged human SIK2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	95.0	CHEMBL5699	Homo sapiens	Activity	%	95.0
	23125116	CHEMBL4806774	Inhibition of human SIK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	96.0	CHEMBL5699	Homo sapiens	Activity	%	96.0
	23125117	CHEMBL4806774	Inhibition of human SIK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5699	Homo sapiens	Activity	%	100.0
	23127363	CHEMBL4807588	Inhibition of SIK2 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)ccnc3C)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4878274	=	IC50	nM	641.0	CHEMBL5699	Homo sapiens	IC50	nM	641.0
	23127364	CHEMBL4807588	Inhibition of SIK2 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3ncccc3C)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4865214	=	IC50	nM	427.0	CHEMBL5699	Homo sapiens	IC50	nM	427.0
	23127365	CHEMBL4807588	Inhibition of SIK2 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Br)ccnc3C)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4865345	=	IC50	nM	1540.0	CHEMBL5699	Homo sapiens	IC50	nM	1540.0
	23127366	CHEMBL4807588	Inhibition of SIK2 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cncc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4869199	=	IC50	nM	130.0	CHEMBL5699	Homo sapiens	IC50	nM	130.0
	23127367	CHEMBL4807588	Inhibition of SIK2 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cncc3C)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4857583	=	IC50	nM	119.0	CHEMBL5699	Homo sapiens	IC50	nM	119.0
	23127368	CHEMBL4807588	Inhibition of SIK2 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3cccnc3C)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4872654	=	IC50	nM	385.0	CHEMBL5699	Homo sapiens	IC50	nM	385.0
	23127369	CHEMBL4807588	Inhibition of SIK2 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	IC50	nM	11.7	CHEMBL5699	Homo sapiens	IC50	nM	11.7
	23127370	CHEMBL4807588	Inhibition of SIK2 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)nn(C)c3C)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4859689	=	IC50	nM	4440.0	CHEMBL5699	Homo sapiens	IC50	nM	4440.0
	23127371	CHEMBL4807588	Inhibition of SIK2 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)noc3C)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4850733	=	IC50	nM	232.0	CHEMBL5699	Homo sapiens	IC50	nM	232.0
	23127372	CHEMBL4807588	Inhibition of SIK2 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(N2CCN(C)CC2)n1		CHEMBL4851745	=	IC50	nM	138.0	CHEMBL5699	Homo sapiens	IC50	nM	138.0
	23127373	CHEMBL4807588	Inhibition of SIK2 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(NCCO)cc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)n1		CHEMBL4857318	=	IC50	nM	470.0	CHEMBL5699	Homo sapiens	IC50	nM	470.0
	23127374	CHEMBL4807588	Inhibition of SIK2 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)NC3CN4CCC3CC4)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4856384	=	IC50	nM	1940.0	CHEMBL5699	Homo sapiens	IC50	nM	1940.0
	23127375	CHEMBL4807588	Inhibition of SIK2 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	IC50	nM	60.0	CHEMBL5699	Homo sapiens	IC50	nM	60.0
	23127376	CHEMBL4807588	Inhibition of SIK2 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	3.0	CHEMBL5699	Homo sapiens	IC50	nM	3.0
	23127377	CHEMBL4807588	Inhibition of SIK2 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)csc3C)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4847716	=	IC50	nM	10.0	CHEMBL5699	Homo sapiens	IC50	nM	10.0
	23127378	CHEMBL4807588	Inhibition of SIK2 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4859969	=	IC50	nM	2.0	CHEMBL5699	Homo sapiens	IC50	nM	2.0
	23127379	CHEMBL4807588	Inhibition of SIK2 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	CC(=O)N1CCN(c2cc(Nc3ncc(C(=O)Nc4c(C)csc4Cl)s3)nc(C)n2)CC1		CHEMBL4865466	=	IC50	nM	25.0	CHEMBL5699	Homo sapiens	IC50	nM	25.0
	23127380	CHEMBL4807588	Inhibition of SIK2 (unknown origin) using RBER-CHKtide as substrate in presence of [32P]gammaATP by microplate scintillation counter analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(C)CC2)n1		CHEMBL4875238	=	IC50	nM	10.0	CHEMBL5699	Homo sapiens	IC50	nM	10.0
	23128581	CHEMBL4808002	Inhibition of SIK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL5699	Homo sapiens	Activity	%	25.0
	23128582	CHEMBL4808002	Inhibition of SIK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	<	Activity	%	25.0	CHEMBL5699	Homo sapiens	Activity	%	25.0
	23128583	CHEMBL4808002	Inhibition of SIK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL5699	Homo sapiens	Activity	%	25.0
Not Active	23317654	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23318122	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23318788	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	95.0	CHEMBL5699	Homo sapiens	% Control	%	95.0
Not Active	23319272	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23319908	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23320384	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23321062	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23321530	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23322160	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	89.0	CHEMBL5699	Homo sapiens	% Control	%	89.0
Not Active	23322628	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	96.0	CHEMBL5699	Homo sapiens	% Control	%	96.0
Not Active	23323317	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	95.0	CHEMBL5699	Homo sapiens	% Control	%	95.0
Not Active	23323785	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23324639	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23325274	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23325742	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	91.0	CHEMBL5699	Homo sapiens	% Control	%	91.0
Not Active	23326389	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23326857	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23327557	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	96.0	CHEMBL5699	Homo sapiens	% Control	%	96.0
Not Active	23328025	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23328612	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23329080	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23329528	CHEMBL4881235	SIK2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	101.0	CHEMBL5699	Homo sapiens	% residual kinase activity	%	101.0
Not Active	23330026	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23330494	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23331250	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23331718	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23332305	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	94.2	CHEMBL5699	Homo sapiens	% Control	%	94.2
Not Active	23332771	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23333489	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	87.8	CHEMBL5699	Homo sapiens	% Control	%	87.8
Not Active	23334128	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23334596	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23335575	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23336043	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23336670	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23337138	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	92.0	CHEMBL5699	Homo sapiens	% Control	%	92.0
Not Active	23337773	CHEMBL4882144	SNF1LK2 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	97.5	CHEMBL5699	Homo sapiens	% Ctrl	%	97.5
Not Active	23338219	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	93.0	CHEMBL5699	Homo sapiens	% Control	%	93.0
Not Active	23338687	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23339299	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23339767	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23340404	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23340872	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23341529	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23341997	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23342613	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	78.0	CHEMBL5699	Homo sapiens	% Control	%	78.0
Not Active	23343081	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23343711	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23344179	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	90.0	CHEMBL5699	Homo sapiens	% Control	%	90.0
Not Active	23344817	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	91.0	CHEMBL5699	Homo sapiens	% Control	%	91.0
Not Active	23345390	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23345858	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23346435	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	95.7	CHEMBL5699	Homo sapiens	% Control	%	95.7
Not Active	23346903	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	88.9	CHEMBL5699	Homo sapiens	% Control	%	88.9
Not Active	23347503	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	85.7	CHEMBL5699	Homo sapiens	% Control	%	85.7
Not Active	23347995	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	94.0	CHEMBL5699	Homo sapiens	% Control	%	94.0
Not Active	23348574	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23349042	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23349629	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23350247	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23350715	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23351320	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	99.0	CHEMBL5699	Homo sapiens	% Control	%	99.0
Not Active	23351788	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	93.0	CHEMBL5699	Homo sapiens	% Control	%	93.0
Not Active	23352225	CHEMBL4882914	SNF1LK2 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	7.084	CHEMBL5699	Homo sapiens	% Inhibition	%	7.084
Not Active	23352812	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	87.0	CHEMBL5699	Homo sapiens	% Control	%	87.0
Not Active	23353280	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23354162	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23354630	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23355362	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23355830	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23356466	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23356934	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23357543	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	96.0	CHEMBL5699	Homo sapiens	% Control	%	96.0
Not Active	23358190	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23358658	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23359244	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	86.4	CHEMBL5699	Homo sapiens	% Control	%	86.4
Not Active	23359842	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23360310	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23360895	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23361363	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23361936	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23362472	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23362940	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	90.0	CHEMBL5699	Homo sapiens	% Control	%	90.0
Not Active	23363340	CHEMBL4883207	NanoBRET (SGC Frankfurt) (SIK2)	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		IC50	nM	125.0	CHEMBL5699	Homo sapiens	IC50	nM	125.0
Not Active	23363355	CHEMBL4883207	NanoBRET (SGC Frankfurt) (SIK2)	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1	Non standard unit for type	CHEMBL4576555	>	IC50	M	10.0	CHEMBL5699	Homo sapiens	IC50	M	10.0
Not Active	23364582	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23365050	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23365789	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	96.0	CHEMBL5699	Homo sapiens	% Control	%	96.0
Not Active	23366332	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23366922	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23367390	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23367747	CHEMBL4884100	SNF1LK2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	86.0	CHEMBL5699	Homo sapiens	% Residual activity with Skepinone-L	%	86.0
Not Active	23368268	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	89.0	CHEMBL5699	Homo sapiens	% Control	%	89.0
Not Active	23368736	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23369335	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	79.0	CHEMBL5699	Homo sapiens	% Control	%	79.0
Not Active	23369803	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	59.0	CHEMBL5699	Homo sapiens	% Control	%	59.0
Not Active	23370244	CHEMBL4884483	SIK2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	68.0	CHEMBL5699	Homo sapiens	% residual kinase activity	%	68.0
Not Active	23370771	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	69.0	CHEMBL5699	Homo sapiens	% Control	%	69.0
Not Active	23371239	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	93.0	CHEMBL5699	Homo sapiens	% Control	%	93.0
Not Active	23372048	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23372516	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	86.0	CHEMBL5699	Homo sapiens	% Control	%	86.0
	23372892	CHEMBL4884857	QIK(SIK2LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL5699	Homo sapiens	pIC50		6.0
	23373301	CHEMBL4885148	QIK(SIK2LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL5699	Homo sapiens	pIC50		6.0
	23373656	CHEMBL4885433	QIK(SIK2LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5699	Homo sapiens	pIC50		6.0
Not Active	23375101	CHEMBL4886089	SIK2 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	12.0	CHEMBL5699	Homo sapiens	% Inhibition	%	12.0
Not Active	23375943	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23376411	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23376988	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	86.0	CHEMBL5699	Homo sapiens	% Control	%	86.0
Not Active	23377456	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	96.0	CHEMBL5699	Homo sapiens	% Control	%	96.0
Not Active	23378316	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	88.0	CHEMBL5699	Homo sapiens	% Control	%	88.0
Not Active	23378784	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	88.0	CHEMBL5699	Homo sapiens	% Control	%	88.0
Not Active	23379951	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23380419	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23381113	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23381761	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23382229	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Not Active	23382853	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL5699	Homo sapiens	% Control	%	100.0
Slightly Active	23383321	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	41.0	CHEMBL5699	Homo sapiens	% Control	%	41.0
Not Active	23383988	CHEMBL4887590	SNF1LK2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	84.0	CHEMBL5699	Homo sapiens	% Ctrl	%	84.0
Not Active	23384465	CHEMBL4888060	SIK2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	3.68	CHEMBL5699	Homo sapiens	% inhibition	%	3.68
Not Active	23385236	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	87.0	CHEMBL5699	Homo sapiens	% Control	%	87.0
Not Active	23385703	CHEMBL4879960	KinomeScan assay: inhibition of SIK2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	92.0	CHEMBL5699	Homo sapiens	% Control	%	92.0
